Effect of Transcranial Direct Current Stimulation associated with aerobic exercise on the autonomic modulation of hemiparetic individuals due to stroke: a study protocol for a double-blind randomized controlled trial

Solange Zilli Lo Presti Heinz; Katia De Angelis; Glauber Heinz; Ariane Viana; Fernanda Marciano Consolim-Colombo; Agatha Calegari Bonfadine; Ruthe Rodrigues Nemesio; Claudia Gabriella Ribolli Bacalhau; Rafael Alves de Oliveira; Cristina Sayuri Miyamura; João Carlos Ferrari Corrêa; Fernanda Ishida Corrêa

doi:10.12688/f1000research.36394.2

Home Browse Effect of Transcranial Direct Current Stimulation associated with...

ALL Metrics

Views

Downloads

Get PDF

Get XML

Export

▬

✚

Study Protocol

Clinical trial

Revised

Effect of Transcranial Direct Current Stimulation associated with aerobic exercise on the autonomic modulation of hemiparetic individuals due to stroke: a study protocol for a double-blind randomized controlled trial

[version 2; peer review: 1 approved, 2 not approved]

Solange Zilli Lo Presti Heinz¹, Katia De Angelis², Glauber Heinz¹, [...] Ariane Viana³, Fernanda Marciano Consolim-Colombo³, Agatha Calegari Bonfadine¹, Ruthe Rodrigues Nemesio¹, Claudia Gabriella Ribolli Bacalhau¹, Rafael Alves de Oliveira¹, Cristina Sayuri Miyamura¹, João Carlos Ferrari Corrêa¹, Fernanda Ishida Corrêa ¹

Solange Zilli Lo Presti Heinz¹, Katia De Angelis², [...] Glauber Heinz¹, Ariane Viana³, Fernanda Marciano Consolim-Colombo³, Agatha Calegari Bonfadine¹, Ruthe Rodrigues Nemesio¹, Claudia Gabriella Ribolli Bacalhau¹, Rafael Alves de Oliveira¹, Cristina Sayuri Miyamura¹, João Carlos Ferrari Corrêa¹, Fernanda Ishida Corrêa ¹

PUBLISHED 11 Oct 2021

Author details Author details

¹ Doctor and Master Program in Rehabilitation Science, Nove de Julho University, São Paulo/SP, São Paulo, 01504-001, Brazil
² Department of Physiology, Federal of Sao Paulo University, São Paulo/SP, São Paulo, 04021-001, Brazil
³ Doctor and Master Program in Medicine School, Nove de Julho University, São Paulo/SP, São Paulo, 01504-001, Brazil

Solange Zilli Lo Presti Heinz
Roles: Conceptualization, Data Curation, Formal Analysis, Investigation, Methodology, Project Administration, Resources, Writing – Original Draft Preparation, Writing – Review & Editing

Katia De Angelis
Roles: Data Curation, Formal Analysis, Methodology, Supervision, Writing – Review & Editing

Glauber Heinz
Roles: Conceptualization, Data Curation, Formal Analysis, Investigation, Methodology, Project Administration, Resources, Software, Writing – Original Draft Preparation, Writing – Review & Editing

Ariane Viana
Roles: Data Curation, Formal Analysis, Methodology, Supervision, Writing – Review & Editing

Fernanda Marciano Consolim-Colombo
Roles: Investigation, Methodology, Supervision

Agatha Calegari Bonfadine
Roles: Investigation, Methodology

Ruthe Rodrigues Nemesio
Roles: Investigation, Methodology

Claudia Gabriella Ribolli Bacalhau
Roles: Investigation, Methodology

Rafael Alves de Oliveira
Roles: Investigation, Methodology

Cristina Sayuri Miyamura
Roles: Investigation, Methodology

João Carlos Ferrari Corrêa
Roles: Conceptualization, Formal Analysis, Funding Acquisition, Methodology, Project Administration, Resources, Supervision, Writing – Review & Editing

Fernanda Ishida Corrêa
Roles: Conceptualization, Data Curation, Formal Analysis, Funding Acquisition, Investigation, Methodology, Project Administration, Resources, Supervision, Visualization, Writing – Review & Editing

OPEN PEER REVIEW

REVIEWER STATUS

Abstract

Background: Individuals after a stroke have an imbalance in the autonomic nervous system, which increases the risk of death or recurrent episodes of stroke. Transcranial Direct Current Stimulation (tDCS) combined with aerobic exercise has shown an effect on the modulation of this system.
Objective: The Heart Rate Variability (HRV) and the distance traveled on the exercise bike will be assessed to verify the additional impact of tDCS combined with aerobic exercise on individuals with chronic stroke sequelae.
Methods: The 34 adult individuals with diagnoses of chronic stroke will be randomized into two aerobic exercise intervention groups: G1 (with active tDCS) and G2 (with sham tDCS), three times a week, for 12 weeks.
Procedures: tDCS will be implemented during the aerobic exercise with the anodal electrode positioned over the lateral dorsal prefrontal left cortex, and the cathodal electrode over the contralateral supraorbital region, with 2mA, for 20 minutes. Assessments will be carried out pre, immediately after the intervention, and on the 12th, 24th, 36th interventions, and 30 days later.
The HRV data that are pulse interval (PI), square root of the mean of the squares of the differences between adjacent normal RR intervals (rMSSD), absolute high frequency (HF), absolute low frequency (LF), high and low frequency ratio (LF / HF) will be collected using a cardio frequency meter. The analysis of the distance traveled on the exercise bike before and after interventions will be analyzed in meters.
Discussion: The autonomic control via brain networks after a stroke can be altered and can promote an increase in sympathetic tone, and a higher risk of sudden death or relapse of stroke. It is crucial to demonstrate the effectiveness of available treatments to improve the autonomic function.
Trial registration: The study is registered as a BRAZILIAN CLINICAL TEST RECORD (ReBEC): U1111-1222-4588 on the 2018/10/16

Keywords

Stroke, Autonomic Modulation, Transcranial Direct Current Stimulation, Physical Exercise, Hemiplegia

Corresponding author: Fernanda Ishida Corrêa

Competing interests: No competing interests were disclosed.

Grant information: The Brazilian Agency for the Promotion of the Coordination for the Improvement of Higher Education Personnel (CAPES) supported the research by granting a scholarship to the first author of this study.

Copyright: © 2021 Zilli Lo Presti Heinz S et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to cite: Zilli Lo Presti Heinz S, De Angelis K, Heinz G et al. Effect of Transcranial Direct Current Stimulation associated with aerobic exercise on the autonomic modulation of hemiparetic individuals due to stroke: a study protocol for a double-blind randomized controlled trial [version 2; peer review: 1 approved, 2 not approved]. F1000Research 2021, 10:191 (https://doi.org/10.12688/f1000research.36394.2) First published: 08 Mar 2021, 10:191 (https://doi.org/10.12688/f1000research.36394.1) Latest published: 11 Oct 2021, 10:191 (https://doi.org/10.12688/f1000research.36394.2)

Revised Amendments from Version 1

The new version contains the suggestions from the first reviewer, which made the article more enlightened. As in the intragroup analysis, we added the information that HRV in the time domain with the index of variance, rMSSD and in the frequency domain with absolute, normalized high frequency, and the ratio of LF to HF power. The data that will be used, is the unpaired ANOVA with repetition for parametric data and Friedman test for non-parametric data.

See the authors' detailed response to the review by Rita Khadka

Abbreviations

tDCS: transcranial direct current stimulation

F3: Left dorsolateral prefrontal cortex

HRV: heart rate variability

DLPFC: dorsolateral prefrontal cortex

DT: linear time-domain

FD: frequency-domain

IP: Pulse interval

rMSSD: square root of the mean of the squares of the differences between adjacent normal RR intervals

HF: Absolute high frequency

LF: Absolute low frequency

LF / HF: low frequency and high-frequency ratio

ACE: Addenbrooke Cognitive Exam questionnaire

SSQOL: stroke specific quality of life questionnaire

BDI: beck depression inventory

MMSE: mini mental state examination quiz

Introduction

Dysfunction of the Autonomic Nervous System (ANS) increases the risk of cerebrovascular accident (CVA). In individuals who have already had a stroke, it increases morbidity and mortality, being a reciprocal relationship^1–3. This dysfunction presents itself in the form of increased activation of the sympathetic nervous system, which can cause significant damage in the regulation of heart rate and blood pressure⁴.

Decreased heart rate variability (HRV), indicative of impaired autonomic function, is considered an important post-stroke clinical outcome, since changes in this variability appear to have prognostic value as remaining abnormal in the long term is a predictor of post-stroke mortality^5–7.

Korpelainen et al.⁸ measured the HRV of individuals who suffered a stroke and demonstrated significant suppression of HRV. Barron et al.⁹ showed that cerebral infarction in the right hemisphere and in the left hemisphere can result in decreased HRV.

HRV dysfunction is related to poor outcome in patients with acute brain injury and chronic cerebrovascular event^10–12; Heinz et al.¹³ observed a decrease in HRV in individuals with a 65-month average duration of injury. These findings therefore suggest that monitoring heart rate behavior may become a helpful indicator of the outcome of cerebral injury and show the importance of treatments aimed at modulating this system.

Thus far, studies have investigated the effect of Transcranial Direct Current Stimulation (tDCS) as adjuvant therapy for modulating cardiac autonomic function. In a systemic review, Rossi et al.¹⁴ showed that tDCS is a therapeutic option in autonomic modulation permitting instantaneous ('online') and lasting ('offline') modulation of cortical excitability. Clancy et al.¹⁵ showed that anodic tDCS on the motor cortex of healthy individuals modifies the autonomic nervous system’s balance, leading to sympathetic dominance; Heinz et al.¹³ observed that application of tDCS associated with aerobic exercise in individuals with stroke sequelae tends to modulate parasympathetic action. However, a contradictory result was found by Nguyen et al.¹⁶, who did not observe the efficacy of tDCS in the population having had a stroke.

Justification

There are few studies that have investigated the effects of tDCS on HRV in connection with stroke sequelae. Transcranial direct current stimulation (tDCS) is a non-invasive technique of brain stimulation (NIBS) that consists of applying a constant direct current through electrodes placed on the head^17,18. In a recent meta-analysis Makovac et al.¹⁹ investigated the effects of NIBS on blood pressure (BP), heart rate (HR), and HRV, and indicated that NIBS can affect the autonomic nervous and cardiovascular systems’ activity, with mandatory reductions in heart rate (HR) and increased HRV. Farinatti et al.²⁰ investigated the effect of tDCS applied before an aerobic exercise session in normotensive men; as a result, they observed decreased parasympathetic activity while sympathovagal balance increased after tDCS. These results demonstrated that NIBS applied over the prefrontal cortex (PFC) can indeed modulate the autonomic nervous system’s activity.

Thus, this study aims to investigate the effects on HRV of tDCS applied on the prefrontal cortex, associated with aerobic exercise.

The choice of the prefrontal cortex for stimulation was due to it being an area related to the neural networks that control heart rhythm, as shown by Ter Horst²¹ and by Ter Horst and Postema²², who identified direct and indirect pathways through which the frontal cortex modulates parasympathetic activity by subcortical inputs, and by Thayer and Lane²³, who were the first to link this circuit to HRV.

Benarroch²⁴ and Benarroch²⁵ identified functional units within the central nervous system, called the central autonomic network (CAN), through which the brain controls visceromotor, neuroendocrine, and behavioral responses. The CAN includes several structures, including the ventromedial prefrontal cortex and orbitofrontal cortex. CAN’s primary output is mediated by sympathetic and parasympathetic preganglionic neurons that innervate the heart through the stellate ganglia and the vagus nerve, respectively. Thus, CAN output is directly linked to HRV and is under tonic inhibitory control via prefrontal cortical areas, including the frontal orbital cortex^26,27.

The proposed study

• The main objective is to investigate the effect of tDCS associated with aerobic exercise on heart rate variability (HRV) in chronic stroke immediately after the 1st, 2th, 24^th, and 36^th interventions, and 30 days after the last intervention.

• The secondary objectives are to assess the distance covered during aerobic training on an exercise bike, assess quality of life and cognition after the 12th, 24th, and 36th days of interventions, and 30 days after the last intervention.

Hypotheses

The study hypothesis is that anodic tDCS applied to the left dorsal prefrontal cortex (DPFC) combined with aerobic exercises will enhance the effects of aerobic training on vagal modulation, since the left DPFC has the function of inhibiting the amygdala’s sympathetic excitatory circuit, helping in vagal autonomic regulation²⁸.

Both tDCS in DLPFC, Fregni et al.²⁹ and Ohn et al.³⁰, and aerobic exercise (AE), Mcmorris² can stimulate cognition. Recent studies have combined tDCS and AE in different clinical contexts, including for cognitive training, showing superior effects compared to single technique applications^2,31–34. In a randomized controlled trial, tDCS and AE resulted in greater improvements in multiple cognitive domains in cognitive training with healthy people than did using either technique alone³¹. Ward et al.³¹ and Céspon aet al.³⁵ propose that multimodal approaches, that is, with more than one intervention technique, can elicit synergistic or additive effects and increase efficacy. Thus, this study’s hypothesis is that aerobic training will improve study participants’ cognition and that TDCS added to exercise will enhance these effects.

Methods

Study design

This is a protocol for a double-blind (evaluator and participants), sham controlled, randomized study following the recommendations of the Consolidated Standards of Reporting Trials (CONSORT) (Figure 1) and the recommendations of the standard protocol items for clinical trials (SPIRIT) (Figure 2). The study was approved by the ethics committee of Nove de Julho University, São Paulo, Brazil (CAAE: 97475718.5.0000.5511) and registered in the Brazilian Clinical Trials Registry (ReBEC) (U1111 -1222-4588). Participants will be informed about the research, procedures, risks, and benefits. If they agree, they will sign an informed consent form (Extended data: Appendix 1²⁷).

Figure 1. Flowchart of the study.

Sample recruitment and selection

Thirty-four participants will be enrolled according to the sample calculation of both sexes at Nove de Julho University’s physiotherapy clinics, in São Paulo.

Inclusion and Exclusion Criteria

Inclusion criteria: individuals of both sexes, between 21 and 74 years of age with a minimum of six months since stroke, medical authorization to participate in the study, and having lower limb functional capacity that allows them to pedal an exercise bike, even if needing help from the therapist. The participants who usually ingest beta-blockers will not be excluded, but after the end of the research, analysis will be carried out to compare the HRV of individuals who use this medication with those who do not . Exclusion criteria are individuals with cognitive impairment (≤17) assessed by the mini-mental status exam (MMSE)³⁶, severe heart problems, use of a pacemaker, Parkinson's disease, diabetes, hypertension, non-controlled hypercholesterolemia, kidney disease, and contraindications to the use of tDCS¹⁸.

Withdrawal and discontinuation

Participants may freely withdraw from assessment and therapy at any time. Criteria for termination in the study include participants who are absent more than a week after the start date, and those who became ill or acquire any injury making it impossible for them to perform physical activity.

Sample size

The sample size for this study was established using the results of the rMSSD index of a pilot study with eight subjects (4 for the active tDCS group and 4 for the sham tDCS group) in which the sample power was considered α 0.05 and β of 0.80.

Using the website calculoamostral.bauru.usp.br’s sample calculation tool, the difference between the two HRV averages of the rMSSD index with independent groups was calculated (t test), resulting in a total N=15 individuals. Considering possible losses, 10% was added, totaling N=17 individuals for each group. Therefore, we considered 34 individuals, with effect size d= 0.000077 by Cohen. (Figure 2).

Figure 2. Representation of the sample calculation by the site: calculoamostral.bauru.usp.br from Test t: by the difference between the two averages with independent groups, with α of 0.05 and a β of 0.80 between 2 groups in 4 periods and an effect size by Cohen's d.

Randomization

The allocation of individuals to Group 1 (active tDCS combined with aerobic exercise on the stationary bike) and Group 2 (tDCS sham combined with aerobic exercise on the stationary bike) will take place using the website www.randomized.com by a researcher not involved in the evaluation and intervention.

Study assessments schedule

A study evaluation schedule with standard protocol items is provided in Table 1.

Table 1. Standard protocol items: recommendations for interventional trials of this study.

TIME POINT	Enrollment (T1)	Allocation (T0)	Pre-intervention (T1)	Intervention				Post- intervention
TIME POINT	Enrollment (T1)	Allocation (T0)	Pre-intervention (T1)	T2	T3	T4	T5	T6	T7
ENROLLMENT:
Eligibility screen	X
Informed consent	X
Demographic information	X
Allocation		X
INTERVENTION:
active (anodal) tDCS associate aerobic training
Sham tDCS associate aerobic training
ASSESSMENTS:
Neurological and cardiovascular assessments		X
Primary outcome: HRV			X
SECONDARY OUTCOMES:
Cognition assessments			X						X
Depression assessments			X						X
Quality of life assessments			X
Type of stimulation, real or sham tDCS and adverse effects

Note: Heart Rate Variability (HRV); -T1: one week before intervention; T0: one day before intervention; T1: 20 minutes before intervention; T2: 1st-day session; T3: 12th-day session; T4: 24th-day session; T5: 36th-day session; T6: immediately after the session; T7: 30th-day follow-up after the last training session.

Intervention

Assessments and interventions will be carried out in the morning, always at the same time, to minimize the effects of the circadian cycle. Recommendations will be to continue using medications according to their regular schedule, have a light diet on test days, abstain from caffeine or alcoholic beverages, and smoking, and avoid moderate or excessive efforts on the day before the test day.

Transcranial Direct Current Stimulation. The tDCS DC-Stimulator Plus (NeuroConn) therapy (active or sham) will be combined with aerobic exercise on the stationary bike. The anode electrode will be placed over the left dorsolateral prefrontal cortex (F3), and the return electrode (cathode) will be placed over the contralateral supra-orbital region, defined by the 10/20 electroencephalogram system. A current of 2mA, will be applied for 20 minutes, 10-second linear ramp up / down.

The electrodes used will be of conductive rubber, anode 5x5 cm, and cathode 5x7 cm, wrapped in a cellulose sponge moistened in 0.9% saline solution.

For sham stimulation, all electrode placement procedures will be performed equal to the active tDCS. Nevertheless, the stimulator will only be switched on for 30 seconds, considered a valid control method in tDCS studies³⁷.

Blinding

The NeuroConn DC-STIMULATOR PLUS device has settings that allow selection of the active or sham stimulation mode by inserting codes. A researcher not involved in the procedures will assign the participants as sham or active. The device’s external functioning does not reveal the stimulus mode. Therefore, neither the researcher who applies the intervention nor the individual will know what treatment is being used (double-blind).

After using the tDCS is carried out, participants and researchers will be asked to complete questionnaires about blinding (Extended data: Appendix 2²⁷), adverse effects (Extended data: Appendix 3²⁷), and satisfaction of therapy (Extended data: Appendix 4²⁷).

Aerobic activity

The participant will performer the aerobic activity on a Reebok® RT 445 model N° RBEX49021 exercise bike, 30 minutes a day, with the initial 5 minutes of warm-up, 20 minutes of aerobic activity associated with active tDCS or sham, and the final 5 minutes of cooling down.

The treatment will be carried out three times a week, every other day , over 12 weeks, for a total of 36 sessions³⁸. The initial intensity will be 50% of the reserve heart rate, as tolerated, and will be rising until 5% of the reserve heart rate each week³⁹. The target aerobic intensity will be 50% to 70% of the reserve heart rate.

The following formula {% reserve HR = [(maximum HR - resting HR) x%] + resting HR} will be used to obtain the reserve heart rate (HR). If an individual uses β-blockers, the maximum corrected HR should be calculated with the following formula [(the dosage taken with the drug + 95.58) / 9.74 =% that should be removed from the maximum HR]. The maximum heart rate (HRmax) will be estimated using the Karvonen formula⁴⁰.

HR and oxygen saturation (SpO₂) will be monitored as a protective measure by a portable pulse oximeter UT-100 Polar V800 frequency meter every two minutes of exercise; as well as blood pressure (BP) and the perception of dyspnea and fatigue of the lower limbs by the modified Borg questionnaire⁴¹.

Assessments

Evaluations will be carried out before the 1st and after the 12th, 24th, and 36th interventions, as well as 30 days after the last intervention. Personal data about individuals and the disease will be collected (Extended data: Appendix 5²⁷). The other data will be:

Evaluation of heart rate variability (HRV). CardioSeries software (http://www.danielpenteado.com/cardioseries) will be used to identify correct premature ectopic beats, and undesirable transients will be removed using linear interpolation that alters the signal stationarity. Variances of pulse interval (PI) will be evaluated in the domain of time and frequency using the linear method.

HRV will be measured using the Polar^® V800 heart rate monitor device. The evaluation of cardiac modulation will be performed by recording the RR interval, processed using the Flow software (https://flow.polar.com), calculating the transducer indices of cardiac cycle fluctuation, high-frequency waves (0.15 and 0.4 Hz), low frequency (0.04 to 0.15 Hz), and the interrelation between low frequency and high frequency (0.15 and 0.4 Hz). The raw, unfiltered data will be exported, converted, and stored in an Excel file, used later for the domain of time and frequency.

The indexes obtained by analyzing the RR intervals in the time domain will be the average of the RR pulse interval utilizing absolute variance and the square root of the squared mean of the difference between the normal adjacent RR intervals (rMSSD), expressed in ms. As for the frequency domain, data will be examined through analysis of absolute high frequency (HF) expressed in ms², low absolute frequency (LF) expressed in ms², and the vagal sympathetic balance between low frequency and high frequency (LF/HF).

Distance Traveled. The distance covered (meters) by the participant will be measured by the exercise bike’s digital marker at the end of 30 minutes of aerobic exercise.

The results of distance covered will be compared intragroup (active and sham tDCS) for each moment before the 1st intervention; after the 12th, 24th, and 36th interventions; and 30 days after the last intervention to verify evolution in both.

Cognitive Performance. Cognitive performance of chronic stroke patients will be assessed using Addenbrooke’s Cognitive Exam (ACE)⁴² questionnaire. The evaluator will apply the questionnaire before and after the 1st, 12th, 24th, and 36th interventions and 30 days after the last intervention.

Quality of life assessment. Quality of life will be measured by the Stroke Specific Quality of Life questionnaire (SSQOL)⁴³. The evaluator will apply this questionnaire before and after the 1st, 12th, 24th, and 36th interventions, and 30 days after the last.

Determination of potential confounding factors

Depressive symptoms. The Beck Depression Inventory (BDI)⁴⁴ will be used to assess depressive symptoms. The evaluator will apply the questionnaire before and after the 1st, 12h, 24th, and 36th interventions, and 30 days after the last intervention.

Results will be correlated with the performance of the physical activity⁴⁵.

Statistical analysis. The program SPSS Statistic version 17.0 will be used for statistical analysis.

For measures of central tendency and dispersion, descriptive statistical analysis will be used. To measure the parametric variables, the mean and standard deviation will be used. To measure non-parametric variables, the median and the interquartile range will be used, and to measure the categorical variables, frequency and percentage will be used.

The Shapiro-Wilk normality test, using the unpaired t-test for parametric data and Mann-Whitney for non-parametric data, will be applied to the date.

HRV data (linear methods) will be analyzed in the time domain with variance and rMSSD; the frequency-domain, with the absolute, low-frequency band, high-frequency band; and the low frequency to high-frequency ratio. Acute data will be submitted to the Shapiro-Wilk normality test, using the unpaired t-test for parametric data and Mann-Whitney for non-parametric data, considering the significance level p<0.05 for all conditions.

Heart Rate Variability data between the periods after the 1st, 12th, 24th, and 36th of interventions, and 30 days after the last intervention will be submitted to the Shapiro-Wilk normality test and unpaired repeated measures ANOVA will be used for parametric data. Friedman test with a general linear model for non-parametric data, considering the significance level p<0.05 for all conditions.

The correlation between the root mean square of successive differences between normal heartbeats (rMSSD) index, distance performed in the ergometer bike, the Beck Depression Inventory (BDI), Stroke Specific Quality of Life (SSQOL), and Addenbrooke´s Cognitive Examination (ACE) questionnaire over the three months of interventions will be submitted to the Shapiro-Wilk normality test, using Person's correlation for parametric data and Spearman’s Correlation for non-parametric data.

Discussion

This article provides a detailed description of a prospective, randomized, controlled, double-blind clinical trial designed to demonstrate the effects of combining tDCS and aerobic training with an exercise bike on the autonomic modulation of individuals with hemiparesis due to chronic stroke.

Post-stroke cardiovascular complications are related to derangement of the brain-heart axis, which can be observed by cardiac autonomic dysregulation. As a consequence, there is sympathetic hyperactivity, a reduction in cardiac vagal modulation associated with a decrease in HRV. These changes can last more than six months after the acute cerebrovascular event, increased up to four times as secondary cardiac complications, and mortality^10,46–49.

It has also been observed that patients with stroke sequelae show a decrease in aerobic capacity due to prolonged inactivity which causes greater damage to autonomic cardiac control. Thus, cardiovascular rehabilitation for these patients is important and can be achieved through aerobic training. The average time for aerobic training to result in an adaptive response of the autonomous system is approximately two to three months, with moderate intensity^47,49–51, which makes the rehabilitation process costly both in terms of time and money, causing many individuals to give up during this process.

The use of tDCS in combination with aerobic exercise can be a very important tool, as its ability to stimulate autonomic modulation, as well as its ability to enhance the outcome of therapies, has been shown in literature^{13,15,32,52–54}. In this context, multimodal interventions provide the possibility of initiating neuroplastic processes and superior performance gains compared to monomodal interventions. Aerobic exercise may be able to interact positively with tDCS in inducing synaptic plasticity. Though not tested so far, it may very well be that the combination of these techniques could improve synaptic processing. This reinforcement pathway is potentially mediated by catecholamines^55–57 the result of which may extend to clinical cardiovascular and cognitive improvement.

Furthermore, the advantage of using tDCS is that it is a simple, safe resource, which can be performed in a direct combination, that is, stimulation during exercise. It is relatively easy to apply, cost-effective, and has no known serious side effects. Thus, this feature can easily be applied in almost all real-life environments: health, sports, functional performance, and the treatment of diseases (except in patients with contraindications) without any significant restrictions on body movement^32,33,54.

The evaluation of HRV to monitor the autonomic nervous system is reliable (CV = 5.3-11.5%), Koskinen et al.⁵⁸, and has high reproducibility, Dietrich et al.⁵⁹, Guijt et al.⁶⁰, Mukherjee et al.⁶¹, in addition to being simple and non-invasive, low cost and having high clinical applicability.

If this study presents positive data, it will allow for better prognosis in the rehabilitation of patients with stroke sequelae, with a possible reduction in the time of the cardiac rehabilitation protocol and better clinical adherence, reducing the probability of recurrence of a more severe stroke.

Evaluation status

At this point, participants have been enrolled, and allocation is being done with the perspective of completing collections in June 2021.

Dissemination of results

Results will be communicated to the public through publication as a data set and original research in the relevant scientific journals.

Study limitations

We consider some topics as being possible limitations to our study:

The possible difficulty in recruiting patients due to their limited mobility.

A possible difficulty in analysis due to decreased vagal withdrawal and use of ß-blockers.

Absence of control over modifiable risk factors.

Difficulty getting complimentary examinations for accurate diagnosis of the location and extent of lesions.

Data availability

Underlying data

No underlying data are associated with this article

Extended data

Harvard Dataverse: Effect of Transcranial Direct Current Stimulation associated with aerobic exercise on the autonomic modulation of hemiparetic individuals due to stroke: a study protocol for a double-blind randomized controlled trial, https://doi.org/10.7910/DVN/MUNWDB²⁷

This project contains the following extended data:

• Appendix 1: Clarified Free Consent Term
• Appendix 2: Blinding Questionnaire tDCS Researcher
• Appendix 3: Adverse effect tDCS
• Appendix 4: Evaluation of treatment satisfaction
• Appendix 5: Personal data about the individual
• Register approved by the ethics committee
• Registered in the Brazilian Registry of Clinical Trial (ReBEC)

Reporting guidelines

Harvard Dataverse: SPIRIT checklist and CONSORT flow diagram for ‘Effect of Transcranial Direct Current Stimulation associated with aerobic exercise on the autonomic modulation of hemiparetic individuals due to stroke: a study protocol for a double-blind randomized controlled trial’, https://doi.org/10.7910/DVN/MUNWDB²⁷

Data are available under the terms of the Creative Commons Zero "No rights reserved" data waiver (CC0 1.0 Public domain dedication).

Acknowledgments

The authors thank the Brazilian fostering agency Coordination for the Improvement of Higher Education Personnel (CAPES) for granting a scholarship to the first author and the University Nove de Julho. Funding provided by CAPES.

Faculty Opinions recommended

References

1. Laowattana S, Zeger SL, Lima JA, et al.: Left insular stroke is associated with adverse cardiac outcome. Neurology. 2006; 66(4): 477–83; discussion 463. PubMed Abstract | Publisher Full Text
2. McMorris T: History of Research into the Acute Exercise-Cognition Interaction: A Cognitive Psychology Approach. Exerc Interact Neurosci Perspect. 2016; 1–28. Publisher Full Text
3. Huikuri HV, Koistinen MJ, Yli-Mäyry S, et al.: Impaired Low-Frequency Oscillations of Heart Rate in Patients With Prior Acute Myocardial Infarction and Life-Threatening Arrhythmias. Am J Cardiol. 1995; 76(1): 56–60. PubMed Abstract | Publisher Full Text
4. Hilz MJ, Dütsch M: Quantitative studies of autonomic function. Muscle Nerve. 2006; 33(1): 6–20. PubMed Abstract | Publisher Full Text
5. de Bruyne MC, Kors JA, Hoes AW, et al.: Both decreased and increased heart rate variability on the standard 10-second electrocardiogram predict cardiac mortality in the elderly: The Rotterdam study. Am J Epidemiol. 1999; 150(12): 1282–8. PubMed Abstract | Publisher Full Text
6. Stein PK, Fauchier L, Babuty D: Sudden death, arrhythmic events and measurements of heart rate variability [1] (multiple letters). J Am Coll Cardiol. 1999; 34(7): 2148–9. PubMed Abstract | Publisher Full Text
7. Thayer JF, Lane RD: The role of vagal function in the risk for cardiovascular disease and mortality. Biol Psychol. 2007; 74(2): 224–42. PubMed Abstract | Publisher Full Text
8. Korpelainen JT, Sotaniemi KA, Huikuri HV, et al.: Abnormal heart rate variability as a manifestation of autonomic dysfunction in hemispheric brain infarction. Stroke. 1996; 27(11): 2059–63. PubMed Abstract | Publisher Full Text
9. Barron SA, Rogovski Z, Hemli J: Autonomic consequences of cerebral hemisphere infarction. Stroke. 1994; 25(1): 113–6. PubMed Abstract | Publisher Full Text
10. Mäkikallio AM, Mäkikallio TH, Korpelainen JT, et al.: Heart rate dynamics predict poststroke mortality. Neurology. 2004; 62(10): 1822–6. PubMed Abstract | Publisher Full Text
11. Montano N, Gnecchi-Ruscone T, Porta A, et al.: Presence of vasomotor and respiratory rhythms in the discharge of single medullary neurons involved in the regulation of cardiovascular system. J Auton Nerv Syst. 1996; 57(1–2): 116–22. PubMed Abstract | Publisher Full Text
12. Cereda C, Ghika J, Maeder P, et al.: Strokes restricted to the insular cortex. Neurology. 2002; 59(12): 1950–5. PubMed Abstract | Publisher Full Text
13. Heinz G, De Angelis K, Dal Corso S, et al.: Effects of Transcranial Direct Current Stimulation (tDCS) and Exercises Treadmill on Autonomic Modulation of Hemiparetic Patients Due To Stroke-Clinic Test, Controlled, Randomized, Double-Blind. Front Neurol. 2020; 10: 1402. PubMed Abstract | Publisher Full Text | Free Full Text
14. Rossi S, Santarnecchi E, Valenza G, et al.: The heart side of brain neuromodulation. Philos Trans A Math Phys Eng Sci. Royal Society of London; 2016; 347(2067): 20150187. PubMed Abstract | Publisher Full Text
15. Clancy JA, Johnson R, Raw R, et al.: Anodal Transcranial Direct Current Stimulation (tDCS) Over the Motor Cortex Increases Sympathetic Nerve Activity. Brain Stimul. 2014; 7(1): 97–104. PubMed Abstract | Publisher Full Text
16. Nguyen TT, Ugwu J, Madhavan S: Anodal tDCS of the lower limb M1 does not acutely affect clinical blood pressure and heart rate in healthy and post stroke individuals. SOJ Neurol. 2015; 2(2): 10.15226/2374-6858/2/2/00118. PubMed Abstract | Publisher Full Text | Free Full Text
17. Boggio PS, Zaghi S, Lopes M, et al.: Modulatory effects of anodal transcranial direct current stimulation on perception and pain thresholds in healthy volunteers. Eur J Neurol. 2008; 15(10): 1124–30. PubMed Abstract | Publisher Full Text
18. Thair H, Holloway AL, Newport R, et al.: Transcranial Direct Current Stimulation (tDCS): A Beginner’s Guide for Design and Implementation. Front Neurosci. 2017; 11: 641. PubMed Abstract | Publisher Full Text | Free Full Text
19. Makovac E, Thayer JF, Ottaviani C: A meta-analysis of non-invasive brain stimulation and autonomic functioning: Implications for brain-heart pathways to cardiovascular disease. Neurosci Biobehav Rev. Elsevier Ltd; 2017; 74(Pt B): 330–41. PubMed Abstract | Publisher Full Text
20. Farinatti P, Cordeiro R, Vogel M, et al.: Postexercise blood pressure and autonomic responses after aerobic exercise following anodal tDCS applied over the medial prefrontal cortex. Neurosci Lett. 2019; 711: 134444. PubMed Abstract | Publisher Full Text
21. Ter Horst GJ: Central Autonomic Control of the Heart, Angina, and Pathogenic Mechanisms of Post-Myocardial Infarction Depression. Eur J Morphol. 1999; 37(4–5): 257–66. PubMed Abstract | Publisher Full Text
22. Ter Horst GJ, Postema F: Forebrain parasympathetic control of heart activity: Retrograde transneuronal viral labeling in rats. Am J Physiol. 1997; 273(6): H2926–30. PubMed Abstract | Publisher Full Text
23. Thayer JF, Lane RD: A model of neurovisceral integration in emotion regulation and dysregulation. J Affect Disord. 2000; 61(3): 201–16. PubMed Abstract | Publisher Full Text
24. Benarroch EE: The Central Autonomic Network: Functional Organization, Dysfunction, and Perspective. Mayo Clin Proc. 1993; 68(10): 988–1001. PubMed Abstract | Publisher Full Text
25. Benarroch EE: 4 - Central Autonomic Control. Prim Auton Nerv Syst Second Ed. 2004; 17–9. Publisher Full Text
26. Saul JP: Beat-To-Beat Variations of Heart Rate Reflect Modulation of Cardiac Autonomic Outflow. Physiology. 1990; 5(1): 32–7. Publisher Full Text
27. Lane RD, McRae K, Reiman EM, et al.: Neural correlates of heart rate variability during emotion. Neuroimage. 2009; 44(1): 213–22. PubMed Abstract | Publisher Full Text
28. Thayer JF, Sternberg E: Beyond Heart Rate Variability: Vagal Regulation of Allostatic Systems. Ann N Y Acad Sci. 2006; 1088(1): 361–72. PubMed Abstract | Publisher Full Text
29. Fregni F, Boggio PS, Nitsche M, et al.: Anodal transcranial direct current stimulation of prefrontal cortex enhances working memory. Exp brain Res. 2005; 166(1): 23–30. PubMed Abstract | Publisher Full Text
30. Ohn SH, Park CI, Yoo WK, et al.: Time-dependent effect of transcranial direct current stimulation on the enhancement of working memory. Neuroreport. 2008; 19(1): 43–7. PubMed Abstract | Publisher Full Text
31. Ward N, Paul E, Watson P, et al.: Enhanced Learning through Multimodal Training: Evidence from a Comprehensive Cognitive, Physical Fitness, and Neuroscience Intervention. Sci Rep. 2017; 7(1): 5808. PubMed Abstract | Publisher Full Text | Free Full Text
32. Okano AH, Fontes EB, Montenegro RA, et al.: Brain stimulation modulates the autonomic nervous system, rating of perceived exertion and performance during maximal exercise. Br J Sports Med. 2015; 49(18): 1213–8. PubMed Abstract | Publisher Full Text
33. Angius L, Hopker J, Mauger AR: The Ergogenic Effects of Transcranial Direct Current Stimulation on Exercise Performance. Front Physiol. 2017; 8: 90. PubMed Abstract | Publisher Full Text | Free Full Text
34. Steinberg F, Pixa NH, Fregni F: A Review of Acute Aerobic Exercise and Transcranial Direct Current Stimulation Effects on Cognitive Functions and Their Potential Synergies. Front Hum Neurosci. 2018; 12: 534. PubMed Abstract | Publisher Full Text | Free Full Text
35. Cespón J, Miniussi C, Pellicciari MC: Interventional programmes to improve cognition during healthy and pathological ageing: Cortical modulations and evidence for brain plasticity. Ageing Res Rev. 2018; 43: 81–98. PubMed Abstract | Publisher Full Text
36. Bertolucci PH, Brucki SM, Campacci SR, et al.: The Mini-Mental State Examination in a general population: impact of educational status. Arq Neuropsiquiatr. 1994; 52(1): 1–7. PubMed Abstract
37. Mendonça M, Fregni F: Neuromodulação com estimulação cerebral não invasiva: aplicação no acidente vascular encefálico, doença de Parkinson e dor crônica ASSIS RD. Manole. Manole, editor. São Paulo: Condutas práticas em fisioterapia neurológica; 2012; 307–39.
38. Timmons JF, Minnock D, Hone M, et al.: Comparison of time-matched aerobic, resistance, or concurrent exercise training in older adults. Scand J Med Sci Sport. 2018; 28(11): 2272–2283. PubMed Abstract | Publisher Full Text
39. Jin H, Jiang Y, Wei Q, et al.: Effects of aerobic cycling training on cardiovascular fitness and heart rate recovery in patients with chronic stroke. NeuroRehabilitation. 2013; 32(2): 327–35. PubMed Abstract | Publisher Full Text
40. Karvonen MJ, Kentala E, Mustala O: The effects of training on heart rate; a longitudinal study. Ann Med Exp Biol Fenn. 1957; 35(3): 307–15. PubMed Abstract
41. Borg GA: Psychophysical bases of perceived exertion. Med Sci Sports Exerc. 1982; 14(5): 377–81. PubMed Abstract
42. Custodio N, Montesinos R, Lira D, et al.: Evolution of short cognitive test performance in stroke patients with vascular cognitive impairment and vascular dementia: Baseline evaluation and follow-up. Dement Neuropsychol. 2017; 11(4): 381–388. PubMed Abstract | Publisher Full Text | Free Full Text
43. Lima R, Teixeira-Salmela L, Magalhães LC, et al.: Propriedades psicométricas da versão brasileira da escala de qualidade de vida específica para acidente vascular encefálico: aplicação do modelo Rasch. Rev Bras Fisioter. 2008; 12(2): 149–156. Publisher Full Text
44. Gorenstein C, Andrade L: Validation of a Portuguese version of the Beck Depression Inventory and the State-Trait Anxiety Inventory in Brazilian subjects. Braz J Med Biol Res. 1996; 29(4): 453–7. PubMed Abstract
45. Gorczynski PF, Coyle M, Gibson K: Depressive symptoms in high-performance athletes and non-athletes: A comparative meta-analysis. Br J Sports Med. BMJ Publishing Group; 2017; 51(18): 1348–1354. PubMed Abstract | Publisher Full Text
46. Buitrago-Ricaurte N, Cintra F, Silva GS: Heart rate variability as an autonomic biomarker in ischemic stroke. Arq Neuropsiquiatr. 2020; 78(11): 724–32. PubMed Abstract | Publisher Full Text
47. Carrión Pérez F, Rodríguez Moreno MS, Carnerero Córdoba L, et al.: Tratamiento de la incontinencia urinaria de esfuerzo mediante telerrehabilitación. Estudio piloto. Med Clin (Barc). 2015; 144(10): 445–8. PubMed Abstract | Publisher Full Text
48. Constantinescu V, Matei D, Ignat B, et al.: Heart Rate Variability Analysis: A Useful Tool to Assess Poststroke Cardiac Dysautonomia. Neurologist. 2020; 25(3): 49–54. PubMed Abstract | Publisher Full Text
49. Dorrance AM, Fink G: Effects of Stroke on the Autonomic Nervous System. In: Compr Physiol. Hoboken, NJ, USA: John Wiley & Sons, Inc.; 2015; 5(3): 1241–63. PubMed Abstract | Publisher Full Text
50. Gambassi BB, Almeida FDF, Almeida AEAF, et al.: Effects of Exercise Training on Cardiovascular and Autonomic Parameters in Stroke Survivors: A Systematic Review. Int J Cardiovasc Sci. 2016; 29(1): 408–13. Reference Source
51. Ivey FM, Hafer-Macko CE, Macko RF: Task-oriented treadmill exercise training in chronic hemiparetic stroke. J Rehabil Res Dev. 2008; 45(2): 249–59. PubMed Abstract | Publisher Full Text | Free Full Text
52. Carnevali L, Pattini E, Sgoifo A, et al.: Effects of prefrontal transcranial direct current stimulation on autonomic and neuroendocrine responses to psychosocial stress in healthy humans. Stress. 2020; 23(1): 26–36. PubMed Abstract | Publisher Full Text
53. Montenegro RA, Farinatti PDV, Fontes EB, et al.: Transcranial direct current stimulation influences the cardiac autonomic nervous control. Neurosci Lett. 2011; 497(1): 32–6. PubMed Abstract | Publisher Full Text
54. Schestatsky P, Simis M, Freeman R, et al.: Non-invasive brain stimulation and the autonomic nervous system. Clin Neurophysiol. 2013; 124: 1716–28. PubMed Abstract | Publisher Full Text
55. Luciana M, Collins PF, Depue RA: Opposing roles for dopamine and serotonin in the modulation of human spatial working memory functions. Cereb Cortex. 1998; 8(3): 218–26. PubMed Abstract | Publisher Full Text
56. Berridge KC: The debate over dopamine’s role in reward: the case for incentive salience. Psychopharmacology (Berl). 2007; 191(3): 391–431. PubMed Abstract | Publisher Full Text
57. Chamberlain SR, Müller U, Blackwell AD, et al.: Noradrenergic modulation of working memory and emotional memory in humans. Psychopharmacology (Berl). 2006; 188(4): 397–407. PubMed Abstract | Publisher Full Text
58. Koskinen T, Kä Hö Nen M, Jula A, et al.: The Cardiovascular Risk in Young Finns Study. Diabet Med. 2009; 26: 354–61.
59. Dietrich D, Rosmalen JGM, Althaus M, et al.: Reproducibility of heart rate variability and baroreflex sensitivity measurements in children. Biol Psychol. 2010; 85(1): 71–8. PubMed Abstract | Publisher Full Text
60. Guijt AM, Sluiter JK, Frings-Dresen MHW: Test-Retest Reliability of Heart Rate Variability and Respiration Rate at Rest and during Light Physical Activity in Normal Subjects. Arch Med Res. 2007; 38(1): 113–20. PubMed Abstract | Publisher Full Text
61. Mukherjee S, Yadav R, Yung I, et al.: Sensitivity to mental effort and test-retest reliability of heart rate variability measures in healthy seniors. Clin Neurophysiol. 2011; 122(10): 2059–66. PubMed Abstract | Publisher Full Text | Free Full Text

Comments on this article Comments (0)

Version 2

VERSION 2 PUBLISHED 08 Mar 2021

Author details Author details

Katia De Angelis
Roles: Data Curation, Formal Analysis, Methodology, Supervision, Writing – Review & Editing

Ariane Viana
Roles: Data Curation, Formal Analysis, Methodology, Supervision, Writing – Review & Editing

Fernanda Marciano Consolim-Colombo
Roles: Investigation, Methodology, Supervision

Agatha Calegari Bonfadine
Roles: Investigation, Methodology

Ruthe Rodrigues Nemesio
Roles: Investigation, Methodology

Claudia Gabriella Ribolli Bacalhau
Roles: Investigation, Methodology

Rafael Alves de Oliveira
Roles: Investigation, Methodology

Cristina Sayuri Miyamura
Roles: Investigation, Methodology

João Carlos Ferrari Corrêa
Roles: Conceptualization, Formal Analysis, Funding Acquisition, Methodology, Project Administration, Resources, Supervision, Writing – Review & Editing

Competing interests

No competing interests were disclosed.

Grant information

The Brazilian Agency for the Promotion of the Coordination for the Improvement of Higher Education Personnel (CAPES) supported the research by granting a scholarship to the first author of this study.

Article Versions (2)

version 2

Revised

Published: 11 Oct 2021, 10:191

https://doi.org/10.12688/f1000research.36394.2

version 1

Published: 08 Mar 2021, 10:191

https://doi.org/10.12688/f1000research.36394.1

© 2021 Zilli Lo Presti Heinz S et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Download

Export To

metrics

	Views	Downloads
F1000Research	-	-
PubMed Central Data from PMC are received and updated monthly.	-	-

Citations

SEE MORE DETAILS

CITE

how to cite this article

Zilli Lo Presti Heinz S, De Angelis K, Heinz G et al. Effect of Transcranial Direct Current Stimulation associated with aerobic exercise on the autonomic modulation of hemiparetic individuals due to stroke: a study protocol for a double-blind randomized controlled trial [version 2; peer review: 1 approved, 2 not approved]. F1000Research 2021, 10:191 (https://doi.org/10.12688/f1000research.36394.2)

NOTE: If applicable, it is important to ensure the information in square brackets after the title is included in all citations of this article.

track

receive updates on this article

Track an article to receive email alerts on any updates to this article.

Open Peer Review

Current Reviewer Status: ?

Key to Reviewer Statuses VIEW HIDE

ApprovedThe paper is scientifically sound in its current form and only minor, if any, improvements are suggested

Approved with reservations A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit.

Not approvedFundamental flaws in the paper seriously undermine the findings and conclusions

Version 2

VERSION 2

PUBLISHED 11 Oct 2021

Revised

Views

Reviewer Report 17 Mar 2022

Socrates Dokos, Graduate School of Biomedical Engineering, University of New South Wales, Sydney, NSW, Australia

Not Approved

https://doi.org/10.5256/f1000research.58277.r123598

This article reports on a clinical trial study protocol to examine the effect of tDCS treatment with aerobic exercise on heart rate variability in stroke patients compared to aerobic exercise alone. The article presents no data from trial participants but describes only the study protocol. Although the reported study design is useful, there are sufficient concerns as to its design, particularly the effect size value (Cohen's d), warranting the inclusion of actual patient trial data results.

Major Comments

The Cohen's d calculation data in figure 2 seems grossly incorrect. Please use a decimal point rather than a comma to enter the numerical data for the sample calculations.
The statement in the abstract “Transcranial Direct Current Stimulation (tDCS) combined with aerobic exercise has shown an effect on the modulation of this system” is misleading, implying this was a finding of the current study. Without clinical trial data, this statement should be modified to something like "Previous studies suggest that Transcranial Direct Current Stimulation (tDCS) combined with aerobic exercise has an effect on the modulation of this system”.

Minor Comments

Page 4, column 1, paragraph 5: replace “Both tDCS in DLPFC 29, 30 and aerobic exercise (AE)2, can stimulate cognition.
Page 4, column 1, paragraph 5: replace “Céspon aet al.” with “Cespón et al.”. and replace “TDCS”with “tDCS”.
Figure 1 flow chart is in too low a resolution and cannot be read.
Page 8, column 2, paragraph 3: replace “…will be applied to the date.” with “…will be applied to the data.”.

Is the rationale for, and objectives of, the study clearly described?

Yes
Is the study design appropriate for the research question?

Partly
Are sufficient details of the methods provided to allow replication by others?

Yes
Are the datasets clearly presented in a useable and accessible format?

No

Competing Interests: No competing interests were disclosed.

Reviewer Expertise: Biomedical Engineering, neuroscience, tDCS, ECT, computational modelling

I confirm that I have read this submission and believe that I have an appropriate level of expertise to state that I do not consider it to be of an acceptable scientific standard, for reasons outlined above.

CITE

Report a concern

Respond or Comment

Views

Reviewer Report 22 Oct 2021

Rita Khadka, Department of Basic and Clinical Physiology, B.P. Koirala Institute of Health Sciences, Dharan, Nepal

Approved

https://doi.org/10.5256/f1000research.58277.r96591

It is well written. All the comments previously suggested are well incorporated in the manuscript. The rationale ... Continue reading

CITE

Report a concern

Respond or Comment

Version 1

VERSION 1

PUBLISHED 08 Mar 2021

Views

Reviewer Report 23 Jun 2021

Brenton Hordacre, Innovation, IMPlementation And Clinical Translation in Health (IIMPACT in Health), Allied Health and Human Performance Academic Unit, University of South Australia, Adelaide, Australia

Not Approved

https://doi.org/10.5256/f1000research.39456.r87186

Thank you for the opportunity to review this study. It is an interesting concept and I have raised a few points the authors should consider below.

In general, this manuscript will need language editing. There are sections

Thank you for the opportunity to review this study. It is an interesting concept and I have raised a few points the authors should consider below.

In general, this manuscript will need language editing. There are sections which do not make sense and paragraphs that are not well formulated. For example, the first two paragraphs of the introduction are 1 sentence long. These could be combined to a single paragraph. Equally, it is highly unusual to see dot points within an academic manuscript. I’d suggest they are removed from the introduction and discussion.
The introduction lacks the relevant background information. As a reader, I am unaware why tDCS or aerobic exercise as therapies delivered over several sessions can modulate the autonomic nervous system. I suggest the authors expand the introduction, possibly utilising references 13-15, rather than just saying the evidence has been noted by some researchers.
I am unclear what the primary and secondary aims of the study are. Is the first dot point the primary aim?
The hypothesises do not align with the aims. Why is there a hypothesis that you are stimulating the left DLPFC? Similarly, why is there a hypothesis that it is possible to observe effects on cognition – the hypothesis should be directional. Eg. we hypothesise that anodal TDCS to the left DLPFC combined with aerobic exercise will increase cognitive function compared to sham tDCS and aerobic exercise.
I am unclear why the consort diagram is provided if no data is collected. Interestingly, it appears 34 participants have already been randomised.
Why is there an upper age limit of 74 years for inclusion criteria?
The cohens D value for the power calculation is extremely low – raising concerns. Please have a biostatistician review. In fact, I cannot replicate the power calculation. I have had a biostatistician perform the calculation and they determined 56 participants are required based on the data provided.
Who is performing the outcome measures?
What is the primary outcome measure(s) and why. What is the reliability/validity and sensitivity of these measures?
The statistical analysis section is inadequate. If there are multiple outcome measurement times and two groups, a repeated measures anova or linear mixed model is appropriate. T-tests are going to increase your error.
The discussion is inadequate. What gap in the literate is this study likely to address and what is the clinical value of running this study. What potential implications could it have for the field. How do you see this study informing clinical practise of scientific knowledge?

Is the rationale for, and objectives of, the study clearly described?

No
Is the study design appropriate for the research question?

Partly
Are sufficient details of the methods provided to allow replication by others?

Partly
Are the datasets clearly presented in a useable and accessible format?

Not applicable

Competing Interests: No competing interests were disclosed.

Reviewer Expertise: Stroke recovery, neuroplasticity, brain stim

CITE

Report a concern

Respond or Comment

Views

Reviewer Report 07 Apr 2021

Rita Khadka, Department of Basic and Clinical Physiology, B.P. Koirala Institute of Health Sciences, Dharan, Nepal

Approved with Reservations

https://doi.org/10.5256/f1000research.39456.r81085

The present study has aimed to investigate the effect of transcranial direct current (tDCS) stimulation associated with aerobic exercise on the autonomic modulation of hemiparetic individuals due to stroke. It is a double-blind randomized controlled trial. The control group will receive sham tDCS. Both groups of patients will do aerobic exercise on an exercise bike for 30 min a day, 3 days a week for 12 weeks. Autonomic modulation will be assessed using heart rate variability (HRV).

I find the study protocol interesting and noble. It has both research and clinical significance. The title of the study protocol is well written, clearly summarizing the main objective of the study. Similarly, the rationale and some portions of the methods of the study are well written/explained. However, I have some comments that need to be discussed for the further improvement of the study.

Comments
Related to the Objectives of the study:

It would be better to modify the objectives of the study (page 3) for better clarity. It can be modified as:

To investigate the effect of transcranial direct current (tDCS) stimulation associated with aerobic exercise on the autonomic modulation of chronic stroke survivors immediately after the 1^st, 12^th, 24^th, and 36^th interventions, and 30 days after the end of the intervention.
To evaluate the effect of tDCS on the distance covered during aerobic training, quality of life, and cognition after the 12^th, 24^th, and 36^th interventions and 30 days after the end of the intervention.

Related to the methods of the study :

In the inclusion and exclusion criteria of the study, nothing is mentioned about patients with chronic stroke along with other complications like diabetes mellitus, chronic kidney disease, Parkinsonism, and some other complications (page 4, last para & page 5, first para).
If patients with chronic stroke along with other complications (like diabetes mellitus, chronic kidney disease, Parkinsonism, and some other complications) are enrolled in the study, it needs to be noted down because these complications decrease HRV. If possible patients with these complications can be excluded from the study. Otherwise, a similar number of such patients enrolled in both the groups may nullify the effects.
For the intra-group comparisons of related data, it would be better to use repeated measure ANOVA for the parametric data and Friedman test for the non-parametric data (under statistical analysis page 7).
It is mentioned that the results of the depressive symptoms will be correlated with the performance of the physical activity (page 7). However, no statistical tool has been discussed under the statistical analysis. Please mention it.
Whether participants will perform aerobic exercise 3 times/days a week successively or on an alternate day (page 7, para 4). It would be better to mention it.
Please mention how you will measure distance traveled (page 7).
When will the quality of life and depressive symptoms be assessed? Not mentioned clearly in the protocol. It would be better to mention the time point for the assessment. Please check for the assessment of the other parameters also and improve them.
Evaluation of heart rate variability is written well. However, it needs some minor modifications. It is written that "rMSSD, expressed in ms²" (page 7). It needs to be corrected as "rMSSD is expressed in ms." It would be better to use the standard abbreviations for the absolute high-frequency and absolute low-frequency powers and their ratios (page 7). Absolute powers are expressed in ms². It can be mentioned.
It would be better to add two more time-domain parameters of HRV; SDNN (standard deviation of R-R intervals) and pNN50 (percentage of the number of pairs of adjacent R-R intervals differing by more than 50 ms). Adding these parameters may strengthen the results.

Is the rationale for, and objectives of, the study clearly described?

Yes
Is the study design appropriate for the research question?

Yes
Are sufficient details of the methods provided to allow replication by others?

Yes
Are the datasets clearly presented in a useable and accessible format?

Not applicable

Competing Interests: No competing interests were disclosed.

Reviewer Expertise: Assessment of cardiovascular autonomic function, heart rate variability, Blood pressure variability, baroreflex sensitivity, exercise physiology, yoga, electroencephalography

I confirm that I have read this submission and believe that I have an appropriate level of expertise to confirm that it is of an acceptable scientific standard, however I have significant reservations, as outlined above.

CITE

Report a concern

Author Response 11 Oct 2021

Solange Zilli Lo Presti Heinz, Doctor and Master Program in Rehabilitation Science, Nove de Julho University, São Paulo/SP, 01504-001, Brazil

11 Oct 2021

Author Response

Dear Reviewer
We are grateful for yours comments and suggestions. We believe that we could improve our manuscript substantially based on these comments. We are submitting the revised version of ... Continue reading Dear Reviewer
We are grateful for yours comments and suggestions. We believe that we could improve our manuscript substantially based on these comments. We are submitting the revised version of our manuscript entitled " Effect of Transcranial Direct Current Stimulation (tDCS) associated with aerobic exercise on the autonomic modulation of hemiparetic individuals due to stroke - Clinical trial protocol, Controlled, Randomized, Double-blind ". We address reviewer points in a point-by-point fashion as shown below.
1.It would be better to modify the study objectives (page 3) for clarity. It can be modified as:
Reviewer's suggestion:
a) To investigate the effect of transcranial direct current stimulation (tDCS) associated with aerobic exercise on the autonomic modulation of chronic stroke survivors immediately after the 1st, 12th, 24th and 36th interventions and 30 days after the end of the intervention.
b) To evaluate the effect of tDCS on the distance covered during aerobic training, quality of life, and cognition after the 12^th, 24^th, and 36^th interventions and 30 days after the end of the intervention.
Answer:
Thank you for your suggestion. Your considerations make our goals better described and clear. Suggested are in lines 93 to 98.
2. Related to the methods of the study:
a) In the inclusion and exclusion criteria of the study, nothing is mentioned about patients with chronic stroke along with other complications like diabetes mellitus, chronic kidney disease, Parkinsonism, and some other complications (page 4, last para & page 5, first para).
b) If patients with chronic stroke along with other complications (like diabetes mellitus, chronic kidney disease, Parkinsonism, and some other complications) are enrolled in the study, it needs to be noted down because these complications decrease HRV. If possible, patients with these complications can be excluded from the study. Otherwise, a similar number of such patients enrolled in both the groups may nullify the effects.
Answer:
Answer:
Thank you for your suggestion.
We agree with your comments. We insert this information in the eligibility criteria. However, some sequelae are very common among Stroke patients, like Diabetes, Hypertension, Hyperlecosterolemia, because of this these comorbidities will be not excluded, but they must be under the control of medication. However, after the end of the research, will be performed the regression analysis to verify if these variables may have interfered with the results. Lines 139 to 140.

3.For the intra-group comparisons of related data, it would be better to use repeated measure ANOVA for the parametric data and Friedman test for the non-parametric data (under statistical analysis page 7).

Answer:
Thank you for your suggestion.
We agree with your comments, and we inserted this information. For HRV (linear methods) the data analyzed between the periods after the 1^st, 12^th, 24^th, and 36^th interventions, and 30 days after the end of the tDCS associated aerobic exercise will be analyzed in the time domain with the index of variance, rMSSD and in the frequency domain with absolute, normalized high frequency and the ratio of LF to HF power. The data will be submitted to the Shapiro-Wilk normality test, using the unpaired ANOVA with repetition parametric data and Friedman test for non-parametric data, considering the significance level p≤0.05 for all conditions. Line 267 to 276.

4. It is mentioned that the results of the depressive symptoms will be correlated with the performance of the physical activity (page 7). However, no statistical tool has been discussed under the statistical analysis. Please mention it.

Answer:
Thank you for your suggestion.

The results of the depression symptoms (BDI) will be correlated with the distance performed on the ergometer bike. The data will be submitted to the Shapiro-Wilk normality test, using the Person´s correlation for parametric data and Sperman's Correlation for non-parametric data.
Lines: 272 to 274.

5.Whether participants will perform aerobic exercise 3 times/days a week successively or on an alternate day (page 7, para 4). It would be better to mention it.

Answer:
Thank you for your suggestion.
The treatment will be carried out three times a week, every other day, for 12 weeks, totaling 36 sessions.

Lines: 44 and 195.

6.Please mention how you will measure distance traveled (page 7).

Answer:
Thank you for your suggestion.
The distance covered (meters) performed by the participant will be measured by the device's digital marker, at the end of the 30 minutes of aerobic exercise, on the exercise bike. Line 233 to 235.

7.When will the quality of life and depressive symptoms be assessed? Not mentioned clearly in the protocol. It would be better to mention the time point for the assessment. Please check for the assessment of the other parameters also and improve them.

Answer:
Thank you for your suggestion.

The cognitive performance of chronic stroke patients will be assessed using the Addenbrooke Cognitive Exam (ACE)³⁴questionnaire. The evaluator will apply the questionnaire before and after the 1st, 12th, 24th, and 36th interventions, and 30 days after the end of the intervention. Line 240 to 243.

Quality of life will be measured by the Stroke Specific Quality of Life questionnaire (SSQOL)³⁵ . The evaluator will apply the questionnaire before and after the 1st, 12th, 24th, and 36th interventions, and 30 days after the end of the intervention. Line 245 to 247.

The Beck Depression Inventory (BDI)³⁶ will be used to assess the depressive symptoms. The evaluator will apply the questionnaire before and after the 1st, 12th, 24th, and 36th interventions, and 30 days after the end of the intervention. Line 250 to 252.

8.Evaluation of heart rate variability is written well. However, it needs some minor modifications. It is written that "rMSSD, expressed in ms²" (page 7). It needs to be corrected as "rMSSD is expressed in ms." It would be better to use the standard abbreviations for the absolute high-frequency and absolute low-frequency powers and their ratios (page 7). Absolute powers are expressed in ms². It can be mentioned.

Answer:
Thank you for your comments.
We correct it. Line: 228 to 231.

9. It would be better to add two more time-domain HRV parameters; SDNN (standard deviation of RR intervals) and pNN50 (percentage of the number of pairs of adjacent RR intervals that differ by more than 50 ms). Adding these parameters can strengthen the results.

Answer:
We appreciate your suggestion. However, the software we will use is the CardioSerie, so it will not be possible to analyze the SDNN and pNN50 data as suggested by the reviewer. But we can add the time-domain index of variance, which equals the SDNN index, and the rMSSD, which equals pNN50. Line 261 to 265.
Dear Reviewer
We are grateful for yours comments and suggestions. We believe that we could improve our manuscript substantially based on these comments. We are submitting the revised version of our manuscript entitled " Effect of Transcranial Direct Current Stimulation (tDCS) associated with aerobic exercise on the autonomic modulation of hemiparetic individuals due to stroke - Clinical trial protocol, Controlled, Randomized, Double-blind ". We address reviewer points in a point-by-point fashion as shown below.
1.It would be better to modify the study objectives (page 3) for clarity. It can be modified as:
Reviewer's suggestion:
a) To investigate the effect of transcranial direct current stimulation (tDCS) associated with aerobic exercise on the autonomic modulation of chronic stroke survivors immediately after the 1st, 12th, 24th and 36th interventions and 30 days after the end of the intervention.
b) To evaluate the effect of tDCS on the distance covered during aerobic training, quality of life, and cognition after the 12^th, 24^th, and 36^th interventions and 30 days after the end of the intervention.
Answer:
Thank you for your suggestion. Your considerations make our goals better described and clear. Suggested are in lines 93 to 98.
2. Related to the methods of the study:
a) In the inclusion and exclusion criteria of the study, nothing is mentioned about patients with chronic stroke along with other complications like diabetes mellitus, chronic kidney disease, Parkinsonism, and some other complications (page 4, last para & page 5, first para).
b) If patients with chronic stroke along with other complications (like diabetes mellitus, chronic kidney disease, Parkinsonism, and some other complications) are enrolled in the study, it needs to be noted down because these complications decrease HRV. If possible, patients with these complications can be excluded from the study. Otherwise, a similar number of such patients enrolled in both the groups may nullify the effects.
Answer:
Answer:
Thank you for your suggestion.
We agree with your comments. We insert this information in the eligibility criteria. However, some sequelae are very common among Stroke patients, like Diabetes, Hypertension, Hyperlecosterolemia, because of this these comorbidities will be not excluded, but they must be under the control of medication. However, after the end of the research, will be performed the regression analysis to verify if these variables may have interfered with the results. Lines 139 to 140.

3.For the intra-group comparisons of related data, it would be better to use repeated measure ANOVA for the parametric data and Friedman test for the non-parametric data (under statistical analysis page 7).

Answer:
Thank you for your suggestion.
We agree with your comments, and we inserted this information. For HRV (linear methods) the data analyzed between the periods after the 1^st, 12^th, 24^th, and 36^th interventions, and 30 days after the end of the tDCS associated aerobic exercise will be analyzed in the time domain with the index of variance, rMSSD and in the frequency domain with absolute, normalized high frequency and the ratio of LF to HF power. The data will be submitted to the Shapiro-Wilk normality test, using the unpaired ANOVA with repetition parametric data and Friedman test for non-parametric data, considering the significance level p≤0.05 for all conditions. Line 267 to 276.

4. It is mentioned that the results of the depressive symptoms will be correlated with the performance of the physical activity (page 7). However, no statistical tool has been discussed under the statistical analysis. Please mention it.

Answer:
Thank you for your suggestion.

The results of the depression symptoms (BDI) will be correlated with the distance performed on the ergometer bike. The data will be submitted to the Shapiro-Wilk normality test, using the Person´s correlation for parametric data and Sperman's Correlation for non-parametric data.
Lines: 272 to 274.

5.Whether participants will perform aerobic exercise 3 times/days a week successively or on an alternate day (page 7, para 4). It would be better to mention it.

Answer:
Thank you for your suggestion.
The treatment will be carried out three times a week, every other day, for 12 weeks, totaling 36 sessions.

Lines: 44 and 195.

6.Please mention how you will measure distance traveled (page 7).

Answer:
Thank you for your suggestion.
The distance covered (meters) performed by the participant will be measured by the device's digital marker, at the end of the 30 minutes of aerobic exercise, on the exercise bike. Line 233 to 235.

7.When will the quality of life and depressive symptoms be assessed? Not mentioned clearly in the protocol. It would be better to mention the time point for the assessment. Please check for the assessment of the other parameters also and improve them.

Answer:
Thank you for your suggestion.

The cognitive performance of chronic stroke patients will be assessed using the Addenbrooke Cognitive Exam (ACE)³⁴questionnaire. The evaluator will apply the questionnaire before and after the 1st, 12th, 24th, and 36th interventions, and 30 days after the end of the intervention. Line 240 to 243.

Quality of life will be measured by the Stroke Specific Quality of Life questionnaire (SSQOL)³⁵ . The evaluator will apply the questionnaire before and after the 1st, 12th, 24th, and 36th interventions, and 30 days after the end of the intervention. Line 245 to 247.

The Beck Depression Inventory (BDI)³⁶ will be used to assess the depressive symptoms. The evaluator will apply the questionnaire before and after the 1st, 12th, 24th, and 36th interventions, and 30 days after the end of the intervention. Line 250 to 252.

8.Evaluation of heart rate variability is written well. However, it needs some minor modifications. It is written that "rMSSD, expressed in ms²" (page 7). It needs to be corrected as "rMSSD is expressed in ms." It would be better to use the standard abbreviations for the absolute high-frequency and absolute low-frequency powers and their ratios (page 7). Absolute powers are expressed in ms². It can be mentioned.

Answer:
Thank you for your comments.
We correct it. Line: 228 to 231.

9. It would be better to add two more time-domain HRV parameters; SDNN (standard deviation of RR intervals) and pNN50 (percentage of the number of pairs of adjacent RR intervals that differ by more than 50 ms). Adding these parameters can strengthen the results.

Answer:
We appreciate your suggestion. However, the software we will use is the CardioSerie, so it will not be possible to analyze the SDNN and pNN50 data as suggested by the reviewer. But we can add the time-domain index of variance, which equals the SDNN index, and the rMSSD, which equals pNN50. Line 261 to 265.
Competing Interests: I declare that I don't have any competing interests Close
Report a concern
Respond or Comment

COMMENTS ON THIS REPORT

Author Response 11 Oct 2021

Solange Zilli Lo Presti Heinz, Doctor and Master Program in Rehabilitation Science, Nove de Julho University, São Paulo/SP, 01504-001, Brazil

11 Oct 2021

Author Response

Dear Reviewer
We are grateful for yours comments and suggestions. We believe that we could improve our manuscript substantially based on these comments. We are submitting the revised version of ... Continue reading Dear Reviewer
We are grateful for yours comments and suggestions. We believe that we could improve our manuscript substantially based on these comments. We are submitting the revised version of our manuscript entitled " Effect of Transcranial Direct Current Stimulation (tDCS) associated with aerobic exercise on the autonomic modulation of hemiparetic individuals due to stroke - Clinical trial protocol, Controlled, Randomized, Double-blind ". We address reviewer points in a point-by-point fashion as shown below.
1.It would be better to modify the study objectives (page 3) for clarity. It can be modified as:
Reviewer's suggestion:
a) To investigate the effect of transcranial direct current stimulation (tDCS) associated with aerobic exercise on the autonomic modulation of chronic stroke survivors immediately after the 1st, 12th, 24th and 36th interventions and 30 days after the end of the intervention.
b) To evaluate the effect of tDCS on the distance covered during aerobic training, quality of life, and cognition after the 12^th, 24^th, and 36^th interventions and 30 days after the end of the intervention.
Answer:
Thank you for your suggestion. Your considerations make our goals better described and clear. Suggested are in lines 93 to 98.
2. Related to the methods of the study:
a) In the inclusion and exclusion criteria of the study, nothing is mentioned about patients with chronic stroke along with other complications like diabetes mellitus, chronic kidney disease, Parkinsonism, and some other complications (page 4, last para & page 5, first para).
b) If patients with chronic stroke along with other complications (like diabetes mellitus, chronic kidney disease, Parkinsonism, and some other complications) are enrolled in the study, it needs to be noted down because these complications decrease HRV. If possible, patients with these complications can be excluded from the study. Otherwise, a similar number of such patients enrolled in both the groups may nullify the effects.
Answer:
Answer:
Thank you for your suggestion.
We agree with your comments. We insert this information in the eligibility criteria. However, some sequelae are very common among Stroke patients, like Diabetes, Hypertension, Hyperlecosterolemia, because of this these comorbidities will be not excluded, but they must be under the control of medication. However, after the end of the research, will be performed the regression analysis to verify if these variables may have interfered with the results. Lines 139 to 140.

3.For the intra-group comparisons of related data, it would be better to use repeated measure ANOVA for the parametric data and Friedman test for the non-parametric data (under statistical analysis page 7).

Answer:
Thank you for your suggestion.
We agree with your comments, and we inserted this information. For HRV (linear methods) the data analyzed between the periods after the 1^st, 12^th, 24^th, and 36^th interventions, and 30 days after the end of the tDCS associated aerobic exercise will be analyzed in the time domain with the index of variance, rMSSD and in the frequency domain with absolute, normalized high frequency and the ratio of LF to HF power. The data will be submitted to the Shapiro-Wilk normality test, using the unpaired ANOVA with repetition parametric data and Friedman test for non-parametric data, considering the significance level p≤0.05 for all conditions. Line 267 to 276.

4. It is mentioned that the results of the depressive symptoms will be correlated with the performance of the physical activity (page 7). However, no statistical tool has been discussed under the statistical analysis. Please mention it.

Answer:
Thank you for your suggestion.

The results of the depression symptoms (BDI) will be correlated with the distance performed on the ergometer bike. The data will be submitted to the Shapiro-Wilk normality test, using the Person´s correlation for parametric data and Sperman's Correlation for non-parametric data.
Lines: 272 to 274.

5.Whether participants will perform aerobic exercise 3 times/days a week successively or on an alternate day (page 7, para 4). It would be better to mention it.

Answer:
Thank you for your suggestion.
The treatment will be carried out three times a week, every other day, for 12 weeks, totaling 36 sessions.

Lines: 44 and 195.

6.Please mention how you will measure distance traveled (page 7).

Answer:
Thank you for your suggestion.
The distance covered (meters) performed by the participant will be measured by the device's digital marker, at the end of the 30 minutes of aerobic exercise, on the exercise bike. Line 233 to 235.

7.When will the quality of life and depressive symptoms be assessed? Not mentioned clearly in the protocol. It would be better to mention the time point for the assessment. Please check for the assessment of the other parameters also and improve them.

Answer:
Thank you for your suggestion.

The cognitive performance of chronic stroke patients will be assessed using the Addenbrooke Cognitive Exam (ACE)³⁴questionnaire. The evaluator will apply the questionnaire before and after the 1st, 12th, 24th, and 36th interventions, and 30 days after the end of the intervention. Line 240 to 243.

Quality of life will be measured by the Stroke Specific Quality of Life questionnaire (SSQOL)³⁵ . The evaluator will apply the questionnaire before and after the 1st, 12th, 24th, and 36th interventions, and 30 days after the end of the intervention. Line 245 to 247.

The Beck Depression Inventory (BDI)³⁶ will be used to assess the depressive symptoms. The evaluator will apply the questionnaire before and after the 1st, 12th, 24th, and 36th interventions, and 30 days after the end of the intervention. Line 250 to 252.

8.Evaluation of heart rate variability is written well. However, it needs some minor modifications. It is written that "rMSSD, expressed in ms²" (page 7). It needs to be corrected as "rMSSD is expressed in ms." It would be better to use the standard abbreviations for the absolute high-frequency and absolute low-frequency powers and their ratios (page 7). Absolute powers are expressed in ms². It can be mentioned.

Answer:
Thank you for your comments.
We correct it. Line: 228 to 231.

9. It would be better to add two more time-domain HRV parameters; SDNN (standard deviation of RR intervals) and pNN50 (percentage of the number of pairs of adjacent RR intervals that differ by more than 50 ms). Adding these parameters can strengthen the results.

Answer:
We appreciate your suggestion. However, the software we will use is the CardioSerie, so it will not be possible to analyze the SDNN and pNN50 data as suggested by the reviewer. But we can add the time-domain index of variance, which equals the SDNN index, and the rMSSD, which equals pNN50. Line 261 to 265.
Dear Reviewer
We are grateful for yours comments and suggestions. We believe that we could improve our manuscript substantially based on these comments. We are submitting the revised version of our manuscript entitled " Effect of Transcranial Direct Current Stimulation (tDCS) associated with aerobic exercise on the autonomic modulation of hemiparetic individuals due to stroke - Clinical trial protocol, Controlled, Randomized, Double-blind ". We address reviewer points in a point-by-point fashion as shown below.
1.It would be better to modify the study objectives (page 3) for clarity. It can be modified as:
Reviewer's suggestion:
a) To investigate the effect of transcranial direct current stimulation (tDCS) associated with aerobic exercise on the autonomic modulation of chronic stroke survivors immediately after the 1st, 12th, 24th and 36th interventions and 30 days after the end of the intervention.
b) To evaluate the effect of tDCS on the distance covered during aerobic training, quality of life, and cognition after the 12^th, 24^th, and 36^th interventions and 30 days after the end of the intervention.
Answer:
Thank you for your suggestion. Your considerations make our goals better described and clear. Suggested are in lines 93 to 98.
2. Related to the methods of the study:
a) In the inclusion and exclusion criteria of the study, nothing is mentioned about patients with chronic stroke along with other complications like diabetes mellitus, chronic kidney disease, Parkinsonism, and some other complications (page 4, last para & page 5, first para).
b) If patients with chronic stroke along with other complications (like diabetes mellitus, chronic kidney disease, Parkinsonism, and some other complications) are enrolled in the study, it needs to be noted down because these complications decrease HRV. If possible, patients with these complications can be excluded from the study. Otherwise, a similar number of such patients enrolled in both the groups may nullify the effects.
Answer:
Answer:
Thank you for your suggestion.
We agree with your comments. We insert this information in the eligibility criteria. However, some sequelae are very common among Stroke patients, like Diabetes, Hypertension, Hyperlecosterolemia, because of this these comorbidities will be not excluded, but they must be under the control of medication. However, after the end of the research, will be performed the regression analysis to verify if these variables may have interfered with the results. Lines 139 to 140.

3.For the intra-group comparisons of related data, it would be better to use repeated measure ANOVA for the parametric data and Friedman test for the non-parametric data (under statistical analysis page 7).

Answer:
Thank you for your suggestion.
We agree with your comments, and we inserted this information. For HRV (linear methods) the data analyzed between the periods after the 1^st, 12^th, 24^th, and 36^th interventions, and 30 days after the end of the tDCS associated aerobic exercise will be analyzed in the time domain with the index of variance, rMSSD and in the frequency domain with absolute, normalized high frequency and the ratio of LF to HF power. The data will be submitted to the Shapiro-Wilk normality test, using the unpaired ANOVA with repetition parametric data and Friedman test for non-parametric data, considering the significance level p≤0.05 for all conditions. Line 267 to 276.

4. It is mentioned that the results of the depressive symptoms will be correlated with the performance of the physical activity (page 7). However, no statistical tool has been discussed under the statistical analysis. Please mention it.

Answer:
Thank you for your suggestion.

The results of the depression symptoms (BDI) will be correlated with the distance performed on the ergometer bike. The data will be submitted to the Shapiro-Wilk normality test, using the Person´s correlation for parametric data and Sperman's Correlation for non-parametric data.
Lines: 272 to 274.

5.Whether participants will perform aerobic exercise 3 times/days a week successively or on an alternate day (page 7, para 4). It would be better to mention it.

Answer:
Thank you for your suggestion.
The treatment will be carried out three times a week, every other day, for 12 weeks, totaling 36 sessions.

Lines: 44 and 195.

6.Please mention how you will measure distance traveled (page 7).

Answer:
Thank you for your suggestion.
The distance covered (meters) performed by the participant will be measured by the device's digital marker, at the end of the 30 minutes of aerobic exercise, on the exercise bike. Line 233 to 235.

7.When will the quality of life and depressive symptoms be assessed? Not mentioned clearly in the protocol. It would be better to mention the time point for the assessment. Please check for the assessment of the other parameters also and improve them.

Answer:
Thank you for your suggestion.

The cognitive performance of chronic stroke patients will be assessed using the Addenbrooke Cognitive Exam (ACE)³⁴questionnaire. The evaluator will apply the questionnaire before and after the 1st, 12th, 24th, and 36th interventions, and 30 days after the end of the intervention. Line 240 to 243.

Quality of life will be measured by the Stroke Specific Quality of Life questionnaire (SSQOL)³⁵ . The evaluator will apply the questionnaire before and after the 1st, 12th, 24th, and 36th interventions, and 30 days after the end of the intervention. Line 245 to 247.

The Beck Depression Inventory (BDI)³⁶ will be used to assess the depressive symptoms. The evaluator will apply the questionnaire before and after the 1st, 12th, 24th, and 36th interventions, and 30 days after the end of the intervention. Line 250 to 252.

8.Evaluation of heart rate variability is written well. However, it needs some minor modifications. It is written that "rMSSD, expressed in ms²" (page 7). It needs to be corrected as "rMSSD is expressed in ms." It would be better to use the standard abbreviations for the absolute high-frequency and absolute low-frequency powers and their ratios (page 7). Absolute powers are expressed in ms². It can be mentioned.

Answer:
Thank you for your comments.
We correct it. Line: 228 to 231.

9. It would be better to add two more time-domain HRV parameters; SDNN (standard deviation of RR intervals) and pNN50 (percentage of the number of pairs of adjacent RR intervals that differ by more than 50 ms). Adding these parameters can strengthen the results.

Answer:
We appreciate your suggestion. However, the software we will use is the CardioSerie, so it will not be possible to analyze the SDNN and pNN50 data as suggested by the reviewer. But we can add the time-domain index of variance, which equals the SDNN index, and the rMSSD, which equals pNN50. Line 261 to 265.
Competing Interests: I declare that I don't have any competing interests Close
Report a concern

Comments on this article Comments (0)

Version 2

VERSION 2 PUBLISHED 08 Mar 2021

Open Peer Review

Reviewer Status

Reviewer Reports

	Invited Reviewers
	1	2	3
Version 2 (revision) 11 Oct 21	read		read
Version 1 08 Mar 21	read	read

Rita Khadka, B.P. Koirala Institute of Health Sciences, Dharan, Nepal
Brenton Hordacre, Innovation, IMPlementation And Clinical Translation in Health (IIMPACT in Health), Allied Health and Human Performance Academic Unit, University of South Australia, Adelaide, Australia
Socrates Dokos, University of New South Wales, Sydney, Australia

Comments on this article

All Comments(0)

Add a comment

Browse by related subjects

Back to all reports

Reviewer Report

5 Views

17 Mar 2022 | for Version 2

Socrates Dokos, Graduate School of Biomedical Engineering, University of New South Wales, Sydney, NSW, Australia

5 Views Cite this report Responses(0)

Not Approved

The Cohen's d calculation data in figure 2 seems grossly incorrect. Please use a decimal point rather than a comma to enter the numerical data for the sample calculations.
The statement in the abstract “Transcranial Direct Current Stimulation (tDCS) combined with aerobic exercise has shown an effect on the modulation of this system” is misleading, implying this was a finding of the current study. Without clinical trial data, this statement should be modified to something like "Previous studies suggest that Transcranial Direct Current Stimulation (tDCS) combined with aerobic exercise has an effect on the modulation of this system”.

Minor Comments

Page 4, column 1, paragraph 5: replace “Both tDCS in DLPFC 29, 30 and aerobic exercise (AE)2, can stimulate cognition.
Page 4, column 1, paragraph 5: replace “Céspon aet al.” with “Cespón et al.”. and replace “TDCS”with “tDCS”.
Figure 1 flow chart is in too low a resolution and cannot be read.
Page 8, column 2, paragraph 3: replace “…will be applied to the date.” with “…will be applied to the data.”.

Is the rationale for, and objectives of, the study clearly described?

Yes
Is the study design appropriate for the research question?

Partly
Are sufficient details of the methods provided to allow replication by others?

Yes
Are the datasets clearly presented in a useable and accessible format?

No

Competing Interests

No competing interests were disclosed.

Reviewer Expertise

Biomedical Engineering, neuroscience, tDCS, ECT, computational modelling

Respond to this report

Responses (0)

Back to all reports

Reviewer Report

5 Views

22 Oct 2021 | for Version 2

Rita Khadka, Department of Basic and Clinical Physiology, B.P. Koirala Institute of Health Sciences, Dharan, Nepal

5 Views Cite this report Responses(0)

Approved

It is well written. All the comments previously suggested are well incorporated in the manuscript. The rationale of the study, objectives, and methods are appropriately explained. It is worth indexing now from my end.

Competing Interests

No competing interests were disclosed.

Reviewer Expertise

Assessment of cardiovascular autonomic function, heart rate variability, Blood pressure variability, baroreflex sensitivity, exercise physiology, yoga, electroencephalography

I confirm that I have read this submission and believe that I have an appropriate level of expertise to confirm that it is of an acceptable scientific standard.

Respond to this report

Responses (0)

Back to all reports

Reviewer Report

21 Views

23 Jun 2021 | for Version 1

21 Views Cite this report Responses(0)

Not Approved

Thank you for the opportunity to review this study. It is an interesting concept and I have raised a few points the authors should consider below.

In general, this manuscript will need language editing. There are sections which do not make sense and paragraphs that are not well formulated. For example, the first two paragraphs of the introduction are 1 sentence long. These could be combined to a single paragraph. Equally, it is highly unusual to see dot points within an academic manuscript. I’d suggest they are removed from the introduction and discussion.
The introduction lacks the relevant background information. As a reader, I am unaware why tDCS or aerobic exercise as therapies delivered over several sessions can modulate the autonomic nervous system. I suggest the authors expand the introduction, possibly utilising references 13-15, rather than just saying the evidence has been noted by some researchers.
I am unclear what the primary and secondary aims of the study are. Is the first dot point the primary aim?
The hypothesises do not align with the aims. Why is there a hypothesis that you are stimulating the left DLPFC? Similarly, why is there a hypothesis that it is possible to observe effects on cognition – the hypothesis should be directional. Eg. we hypothesise that anodal TDCS to the left DLPFC combined with aerobic exercise will increase cognitive function compared to sham tDCS and aerobic exercise.
I am unclear why the consort diagram is provided if no data is collected. Interestingly, it appears 34 participants have already been randomised.
Why is there an upper age limit of 74 years for inclusion criteria?
The cohens D value for the power calculation is extremely low – raising concerns. Please have a biostatistician review. In fact, I cannot replicate the power calculation. I have had a biostatistician perform the calculation and they determined 56 participants are required based on the data provided.
Who is performing the outcome measures?
What is the primary outcome measure(s) and why. What is the reliability/validity and sensitivity of these measures?
The statistical analysis section is inadequate. If there are multiple outcome measurement times and two groups, a repeated measures anova or linear mixed model is appropriate. T-tests are going to increase your error.
The discussion is inadequate. What gap in the literate is this study likely to address and what is the clinical value of running this study. What potential implications could it have for the field. How do you see this study informing clinical practise of scientific knowledge?

Is the rationale for, and objectives of, the study clearly described?

No
Is the study design appropriate for the research question?

Partly
Are sufficient details of the methods provided to allow replication by others?

Partly
Are the datasets clearly presented in a useable and accessible format?

Not applicable

Competing Interests

No competing interests were disclosed.

Reviewer Expertise

Stroke recovery, neuroplasticity, brain stim

Respond to this report

Responses (0)

Back to all reports

Reviewer Report

27 Views

07 Apr 2021 | for Version 1

Rita Khadka, Department of Basic and Clinical Physiology, B.P. Koirala Institute of Health Sciences, Dharan, Nepal

27 Views Cite this report Responses(1)

Approved With Reservations

To investigate the effect of transcranial direct current (tDCS) stimulation associated with aerobic exercise on the autonomic modulation of chronic stroke survivors immediately after the 1^st, 12^th, 24^th, and 36^th interventions, and 30 days after the end of the intervention.
To evaluate the effect of tDCS on the distance covered during aerobic training, quality of life, and cognition after the 12^th, 24^th, and 36^th interventions and 30 days after the end of the intervention.

Related to the methods of the study :

In the inclusion and exclusion criteria of the study, nothing is mentioned about patients with chronic stroke along with other complications like diabetes mellitus, chronic kidney disease, Parkinsonism, and some other complications (page 4, last para & page 5, first para).
If patients with chronic stroke along with other complications (like diabetes mellitus, chronic kidney disease, Parkinsonism, and some other complications) are enrolled in the study, it needs to be noted down because these complications decrease HRV. If possible patients with these complications can be excluded from the study. Otherwise, a similar number of such patients enrolled in both the groups may nullify the effects.
For the intra-group comparisons of related data, it would be better to use repeated measure ANOVA for the parametric data and Friedman test for the non-parametric data (under statistical analysis page 7).
It is mentioned that the results of the depressive symptoms will be correlated with the performance of the physical activity (page 7). However, no statistical tool has been discussed under the statistical analysis. Please mention it.
Whether participants will perform aerobic exercise 3 times/days a week successively or on an alternate day (page 7, para 4). It would be better to mention it.
Please mention how you will measure distance traveled (page 7).
When will the quality of life and depressive symptoms be assessed? Not mentioned clearly in the protocol. It would be better to mention the time point for the assessment. Please check for the assessment of the other parameters also and improve them.
Evaluation of heart rate variability is written well. However, it needs some minor modifications. It is written that "rMSSD, expressed in ms²" (page 7). It needs to be corrected as "rMSSD is expressed in ms." It would be better to use the standard abbreviations for the absolute high-frequency and absolute low-frequency powers and their ratios (page 7). Absolute powers are expressed in ms². It can be mentioned.
It would be better to add two more time-domain parameters of HRV; SDNN (standard deviation of R-R intervals) and pNN50 (percentage of the number of pairs of adjacent R-R intervals differing by more than 50 ms). Adding these parameters may strengthen the results.

Is the rationale for, and objectives of, the study clearly described?

Yes
Is the study design appropriate for the research question?

Yes
Are sufficient details of the methods provided to allow replication by others?

Yes
Are the datasets clearly presented in a useable and accessible format?

Not applicable

Competing Interests

No competing interests were disclosed.

Reviewer Expertise

Assessment of cardiovascular autonomic function, heart rate variability, Blood pressure variability, baroreflex sensitivity, exercise physiology, yoga, electroencephalography

Respond to this report

Responses (1)

Author Response

11 Oct 2021

Solange Zilli Lo Presti Heinz, Doctor and Master Program in Rehabilitation Science, Nove de Julho University, São Paulo/SP, 01504-001, Brazil

Dear Reviewer
We are grateful for yours comments and suggestions. We believe that we could improve our manuscript substantially based on these comments. We are submitting the revised version of our manuscript entitled " Effect of Transcranial Direct Current Stimulation (tDCS) associated with aerobic exercise on the autonomic modulation of hemiparetic individuals due to stroke - Clinical trial protocol, Controlled, Randomized, Double-blind ". We address reviewer points in a point-by-point fashion as shown below.
1.It would be better to modify the study objectives (page 3) for clarity. It can be modified as:
Reviewer's suggestion:
a) To investigate the effect of transcranial direct current stimulation (tDCS) associated with aerobic exercise on the autonomic modulation of chronic stroke survivors immediately after the 1st, 12th, 24th and 36th interventions and 30 days after the end of the intervention.
b) To evaluate the effect of tDCS on the distance covered during aerobic training, quality of life, and cognition after the 12^th, 24^th, and 36^th interventions and 30 days after the end of the intervention.
Answer:
Thank you for your suggestion. Your considerations make our goals better described and clear. Suggested are in lines 93 to 98.
2. Related to the methods of the study:
a) In the inclusion and exclusion criteria of the study, nothing is mentioned about patients with chronic stroke along with other complications like diabetes mellitus, chronic kidney disease, Parkinsonism, and some other complications (page 4, last para & page 5, first para).
b) If patients with chronic stroke along with other complications (like diabetes mellitus, chronic kidney disease, Parkinsonism, and some other complications) are enrolled in the study, it needs to be noted down because these complications decrease HRV. If possible, patients with these complications can be excluded from the study. Otherwise, a similar number of such patients enrolled in both the groups may nullify the effects.
Answer:
Answer:
Thank you for your suggestion.
We agree with your comments. We insert this information in the eligibility criteria. However, some sequelae are very common among Stroke patients, like Diabetes, Hypertension, Hyperlecosterolemia, because of this these comorbidities will be not excluded, but they must be under the control of medication. However, after the end of the research, will be performed the regression analysis to verify if these variables may have interfered with the results. Lines 139 to 140.

3.For the intra-group comparisons of related data, it would be better to use repeated measure ANOVA for the parametric data and Friedman test for the non-parametric data (under statistical analysis page 7).

Answer:
Thank you for your suggestion.
We agree with your comments, and we inserted this information. For HRV (linear methods) the data analyzed between the periods after the 1^st, 12^th, 24^th, and 36^th interventions, and 30 days after the end of the tDCS associated aerobic exercise will be analyzed in the time domain with the index of variance, rMSSD and in the frequency domain with absolute, normalized high frequency and the ratio of LF to HF power. The data will be submitted to the Shapiro-Wilk normality test, using the unpaired ANOVA with repetition parametric data and Friedman test for non-parametric data, considering the significance level p≤0.05 for all conditions. Line 267 to 276.

4. It is mentioned that the results of the depressive symptoms will be correlated with the performance of the physical activity (page 7). However, no statistical tool has been discussed under the statistical analysis. Please mention it.

Answer:
Thank you for your suggestion.

The results of the depression symptoms (BDI) will be correlated with the distance performed on the ergometer bike. The data will be submitted to the Shapiro-Wilk normality test, using the Person´s correlation for parametric data and Sperman's Correlation for non-parametric data.
Lines: 272 to 274.

5.Whether participants will perform aerobic exercise 3 times/days a week successively or on an alternate day (page 7, para 4). It would be better to mention it.

Answer:
Thank you for your suggestion.
The treatment will be carried out three times a week, every other day, for 12 weeks, totaling 36 sessions.

Lines: 44 and 195.

6.Please mention how you will measure distance traveled (page 7).

Answer:
Thank you for your suggestion.
The distance covered (meters) performed by the participant will be measured by the device's digital marker, at the end of the 30 minutes of aerobic exercise, on the exercise bike. Line 233 to 235.

7.When will the quality of life and depressive symptoms be assessed? Not mentioned clearly in the protocol. It would be better to mention the time point for the assessment. Please check for the assessment of the other parameters also and improve them.

Answer:
Thank you for your suggestion.

The cognitive performance of chronic stroke patients will be assessed using the Addenbrooke Cognitive Exam (ACE)³⁴questionnaire. The evaluator will apply the questionnaire before and after the 1st, 12th, 24th, and 36th interventions, and 30 days after the end of the intervention. Line 240 to 243.

Quality of life will be measured by the Stroke Specific Quality of Life questionnaire (SSQOL)³⁵ . The evaluator will apply the questionnaire before and after the 1st, 12th, 24th, and 36th interventions, and 30 days after the end of the intervention. Line 245 to 247.

The Beck Depression Inventory (BDI)³⁶ will be used to assess the depressive symptoms. The evaluator will apply the questionnaire before and after the 1st, 12th, 24th, and 36th interventions, and 30 days after the end of the intervention. Line 250 to 252.

8.Evaluation of heart rate variability is written well. However, it needs some minor modifications. It is written that "rMSSD, expressed in ms²" (page 7). It needs to be corrected as "rMSSD is expressed in ms." It would be better to use the standard abbreviations for the absolute high-frequency and absolute low-frequency powers and their ratios (page 7). Absolute powers are expressed in ms². It can be mentioned.

Answer:
Thank you for your comments.
We correct it. Line: 228 to 231.

9. It would be better to add two more time-domain HRV parameters; SDNN (standard deviation of RR intervals) and pNN50 (percentage of the number of pairs of adjacent RR intervals that differ by more than 50 ms). Adding these parameters can strengthen the results.

Answer:
We appreciate your suggestion. However, the software we will use is the CardioSerie, so it will not be possible to analyze the SDNN and pNN50 data as suggested by the reviewer. But we can add the time-domain index of variance, which equals the SDNN index, and the rMSSD, which equals pNN50. Line 261 to 265.

View more View less

Competing Interests

I declare that I don't have any competing interests

Alongside their report, reviewers assign a status to the article:

Approved - the paper is scientifically sound in its current form and only minor, if any, improvements are suggested

Approved with reservations - A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit.

Not approved - fundamental flaws in the paper seriously undermine the findings and conclusions

[1] 1. Laowattana S, Zeger SL, Lima JA, et al.: Left insular stroke is associated with adverse cardiac outcome. Neurology. 2006; 66(4): 477–83; discussion 463. PubMed Abstract | Publisher Full Text

[2] 2. McMorris T: History of Research into the Acute Exercise-Cognition Interaction: A Cognitive Psychology Approach. Exerc Interact Neurosci Perspect. 2016; 1–28. Publisher Full Text

[3] 3. Huikuri HV, Koistinen MJ, Yli-Mäyry S, et al.: Impaired Low-Frequency Oscillations of Heart Rate in Patients With Prior Acute Myocardial Infarction and Life-Threatening Arrhythmias. Am J Cardiol. 1995; 76(1): 56–60. PubMed Abstract | Publisher Full Text

[4] 4. Hilz MJ, Dütsch M: Quantitative studies of autonomic function. Muscle Nerve. 2006; 33(1): 6–20. PubMed Abstract | Publisher Full Text

[5] 5. de Bruyne MC, Kors JA, Hoes AW, et al.: Both decreased and increased heart rate variability on the standard 10-second electrocardiogram predict cardiac mortality in the elderly: The Rotterdam study. Am J Epidemiol. 1999; 150(12): 1282–8. PubMed Abstract | Publisher Full Text

[6] 6. Stein PK, Fauchier L, Babuty D: Sudden death, arrhythmic events and measurements of heart rate variability [1] (multiple letters). J Am Coll Cardiol. 1999; 34(7): 2148–9. PubMed Abstract | Publisher Full Text

[7] 7. Thayer JF, Lane RD: The role of vagal function in the risk for cardiovascular disease and mortality. Biol Psychol. 2007; 74(2): 224–42. PubMed Abstract | Publisher Full Text

[8] 8. Korpelainen JT, Sotaniemi KA, Huikuri HV, et al.: Abnormal heart rate variability as a manifestation of autonomic dysfunction in hemispheric brain infarction. Stroke. 1996; 27(11): 2059–63. PubMed Abstract | Publisher Full Text

[9] 9. Barron SA, Rogovski Z, Hemli J: Autonomic consequences of cerebral hemisphere infarction. Stroke. 1994; 25(1): 113–6. PubMed Abstract | Publisher Full Text

[10] 10. Mäkikallio AM, Mäkikallio TH, Korpelainen JT, et al.: Heart rate dynamics predict poststroke mortality. Neurology. 2004; 62(10): 1822–6. PubMed Abstract | Publisher Full Text

[11] 11. Montano N, Gnecchi-Ruscone T, Porta A, et al.: Presence of vasomotor and respiratory rhythms in the discharge of single medullary neurons involved in the regulation of cardiovascular system. J Auton Nerv Syst. 1996; 57(1–2): 116–22. PubMed Abstract | Publisher Full Text

[12] 12. Cereda C, Ghika J, Maeder P, et al.: Strokes restricted to the insular cortex. Neurology. 2002; 59(12): 1950–5. PubMed Abstract | Publisher Full Text

[13] 13. Heinz G, De Angelis K, Dal Corso S, et al.: Effects of Transcranial Direct Current Stimulation (tDCS) and Exercises Treadmill on Autonomic Modulation of Hemiparetic Patients Due To Stroke-Clinic Test, Controlled, Randomized, Double-Blind. Front Neurol. 2020; 10: 1402. PubMed Abstract | Publisher Full Text | Free Full Text

[14] 14. Rossi S, Santarnecchi E, Valenza G, et al.: The heart side of brain neuromodulation. Philos Trans A Math Phys Eng Sci. Royal Society of London; 2016; 347(2067): 20150187. PubMed Abstract | Publisher Full Text

[15] 15. Clancy JA, Johnson R, Raw R, et al.: Anodal Transcranial Direct Current Stimulation (tDCS) Over the Motor Cortex Increases Sympathetic Nerve Activity. Brain Stimul. 2014; 7(1): 97–104. PubMed Abstract | Publisher Full Text

[16] 16. Nguyen TT, Ugwu J, Madhavan S: Anodal tDCS of the lower limb M1 does not acutely affect clinical blood pressure and heart rate in healthy and post stroke individuals. SOJ Neurol. 2015; 2(2): 10.15226/2374-6858/2/2/00118. PubMed Abstract | Publisher Full Text | Free Full Text

[17] 17. Boggio PS, Zaghi S, Lopes M, et al.: Modulatory effects of anodal transcranial direct current stimulation on perception and pain thresholds in healthy volunteers. Eur J Neurol. 2008; 15(10): 1124–30. PubMed Abstract | Publisher Full Text

[18] 18. Thair H, Holloway AL, Newport R, et al.: Transcranial Direct Current Stimulation (tDCS): A Beginner’s Guide for Design and Implementation. Front Neurosci. 2017; 11: 641. PubMed Abstract | Publisher Full Text | Free Full Text

[19] 19. Makovac E, Thayer JF, Ottaviani C: A meta-analysis of non-invasive brain stimulation and autonomic functioning: Implications for brain-heart pathways to cardiovascular disease. Neurosci Biobehav Rev. Elsevier Ltd; 2017; 74(Pt B): 330–41. PubMed Abstract | Publisher Full Text

[20] 20. Farinatti P, Cordeiro R, Vogel M, et al.: Postexercise blood pressure and autonomic responses after aerobic exercise following anodal tDCS applied over the medial prefrontal cortex. Neurosci Lett. 2019; 711: 134444. PubMed Abstract | Publisher Full Text

[21] 21. Ter Horst GJ: Central Autonomic Control of the Heart, Angina, and Pathogenic Mechanisms of Post-Myocardial Infarction Depression. Eur J Morphol. 1999; 37(4–5): 257–66. PubMed Abstract | Publisher Full Text

[22] 22. Ter Horst GJ, Postema F: Forebrain parasympathetic control of heart activity: Retrograde transneuronal viral labeling in rats. Am J Physiol. 1997; 273(6): H2926–30. PubMed Abstract | Publisher Full Text

[23] 23. Thayer JF, Lane RD: A model of neurovisceral integration in emotion regulation and dysregulation. J Affect Disord. 2000; 61(3): 201–16. PubMed Abstract | Publisher Full Text

[24] 24. Benarroch EE: The Central Autonomic Network: Functional Organization, Dysfunction, and Perspective. Mayo Clin Proc. 1993; 68(10): 988–1001. PubMed Abstract | Publisher Full Text

[25] 25. Benarroch EE: 4 - Central Autonomic Control. Prim Auton Nerv Syst Second Ed. 2004; 17–9. Publisher Full Text

[26] 26. Saul JP: Beat-To-Beat Variations of Heart Rate Reflect Modulation of Cardiac Autonomic Outflow. Physiology. 1990; 5(1): 32–7. Publisher Full Text

[27] 27. Lane RD, McRae K, Reiman EM, et al.: Neural correlates of heart rate variability during emotion. Neuroimage. 2009; 44(1): 213–22. PubMed Abstract | Publisher Full Text

[28] 28. Thayer JF, Sternberg E: Beyond Heart Rate Variability: Vagal Regulation of Allostatic Systems. Ann N Y Acad Sci. 2006; 1088(1): 361–72. PubMed Abstract | Publisher Full Text

[29] 29. Fregni F, Boggio PS, Nitsche M, et al.: Anodal transcranial direct current stimulation of prefrontal cortex enhances working memory. Exp brain Res. 2005; 166(1): 23–30. PubMed Abstract | Publisher Full Text

[30] 30. Ohn SH, Park CI, Yoo WK, et al.: Time-dependent effect of transcranial direct current stimulation on the enhancement of working memory. Neuroreport. 2008; 19(1): 43–7. PubMed Abstract | Publisher Full Text

[31] 31. Ward N, Paul E, Watson P, et al.: Enhanced Learning through Multimodal Training: Evidence from a Comprehensive Cognitive, Physical Fitness, and Neuroscience Intervention. Sci Rep. 2017; 7(1): 5808. PubMed Abstract | Publisher Full Text | Free Full Text

[32] 32. Okano AH, Fontes EB, Montenegro RA, et al.: Brain stimulation modulates the autonomic nervous system, rating of perceived exertion and performance during maximal exercise. Br J Sports Med. 2015; 49(18): 1213–8. PubMed Abstract | Publisher Full Text

[33] 33. Angius L, Hopker J, Mauger AR: The Ergogenic Effects of Transcranial Direct Current Stimulation on Exercise Performance. Front Physiol. 2017; 8: 90. PubMed Abstract | Publisher Full Text | Free Full Text

[34] 34. Steinberg F, Pixa NH, Fregni F: A Review of Acute Aerobic Exercise and Transcranial Direct Current Stimulation Effects on Cognitive Functions and Their Potential Synergies. Front Hum Neurosci. 2018; 12: 534. PubMed Abstract | Publisher Full Text | Free Full Text

[35] 35. Cespón J, Miniussi C, Pellicciari MC: Interventional programmes to improve cognition during healthy and pathological ageing: Cortical modulations and evidence for brain plasticity. Ageing Res Rev. 2018; 43: 81–98. PubMed Abstract | Publisher Full Text

[36] 36. Bertolucci PH, Brucki SM, Campacci SR, et al.: The Mini-Mental State Examination in a general population: impact of educational status. Arq Neuropsiquiatr. 1994; 52(1): 1–7. PubMed Abstract

[37] 37. Mendonça M, Fregni F: Neuromodulação com estimulação cerebral não invasiva: aplicação no acidente vascular encefálico, doença de Parkinson e dor crônica ASSIS RD. Manole. Manole, editor. São Paulo: Condutas práticas em fisioterapia neurológica; 2012; 307–39.

[38] 38. Timmons JF, Minnock D, Hone M, et al.: Comparison of time-matched aerobic, resistance, or concurrent exercise training in older adults. Scand J Med Sci Sport. 2018; 28(11): 2272–2283. PubMed Abstract | Publisher Full Text

[39] 39. Jin H, Jiang Y, Wei Q, et al.: Effects of aerobic cycling training on cardiovascular fitness and heart rate recovery in patients with chronic stroke. NeuroRehabilitation. 2013; 32(2): 327–35. PubMed Abstract | Publisher Full Text

[40] 40. Karvonen MJ, Kentala E, Mustala O: The effects of training on heart rate; a longitudinal study. Ann Med Exp Biol Fenn. 1957; 35(3): 307–15. PubMed Abstract

[41] 41. Borg GA: Psychophysical bases of perceived exertion. Med Sci Sports Exerc. 1982; 14(5): 377–81. PubMed Abstract

[42] 42. Custodio N, Montesinos R, Lira D, et al.: Evolution of short cognitive test performance in stroke patients with vascular cognitive impairment and vascular dementia: Baseline evaluation and follow-up. Dement Neuropsychol. 2017; 11(4): 381–388. PubMed Abstract | Publisher Full Text | Free Full Text

[43] 43. Lima R, Teixeira-Salmela L, Magalhães LC, et al.: Propriedades psicométricas da versão brasileira da escala de qualidade de vida específica para acidente vascular encefálico: aplicação do modelo Rasch. Rev Bras Fisioter. 2008; 12(2): 149–156. Publisher Full Text

[44] 44. Gorenstein C, Andrade L: Validation of a Portuguese version of the Beck Depression Inventory and the State-Trait Anxiety Inventory in Brazilian subjects. Braz J Med Biol Res. 1996; 29(4): 453–7. PubMed Abstract

[45] 45. Gorczynski PF, Coyle M, Gibson K: Depressive symptoms in high-performance athletes and non-athletes: A comparative meta-analysis. Br J Sports Med. BMJ Publishing Group; 2017; 51(18): 1348–1354. PubMed Abstract | Publisher Full Text

[46] 46. Buitrago-Ricaurte N, Cintra F, Silva GS: Heart rate variability as an autonomic biomarker in ischemic stroke. Arq Neuropsiquiatr. 2020; 78(11): 724–32. PubMed Abstract | Publisher Full Text

[47] 47. Carrión Pérez F, Rodríguez Moreno MS, Carnerero Córdoba L, et al.: Tratamiento de la incontinencia urinaria de esfuerzo mediante telerrehabilitación. Estudio piloto. Med Clin (Barc). 2015; 144(10): 445–8. PubMed Abstract | Publisher Full Text

[48] 48. Constantinescu V, Matei D, Ignat B, et al.: Heart Rate Variability Analysis: A Useful Tool to Assess Poststroke Cardiac Dysautonomia. Neurologist. 2020; 25(3): 49–54. PubMed Abstract | Publisher Full Text

[49] 49. Dorrance AM, Fink G: Effects of Stroke on the Autonomic Nervous System. In: Compr Physiol. Hoboken, NJ, USA: John Wiley & Sons, Inc.; 2015; 5(3): 1241–63. PubMed Abstract | Publisher Full Text

[50] 50. Gambassi BB, Almeida FDF, Almeida AEAF, et al.: Effects of Exercise Training on Cardiovascular and Autonomic Parameters in Stroke Survivors: A Systematic Review. Int J Cardiovasc Sci. 2016; 29(1): 408–13. Reference Source

[51] 51. Ivey FM, Hafer-Macko CE, Macko RF: Task-oriented treadmill exercise training in chronic hemiparetic stroke. J Rehabil Res Dev. 2008; 45(2): 249–59. PubMed Abstract | Publisher Full Text | Free Full Text

[52] 52. Carnevali L, Pattini E, Sgoifo A, et al.: Effects of prefrontal transcranial direct current stimulation on autonomic and neuroendocrine responses to psychosocial stress in healthy humans. Stress. 2020; 23(1): 26–36. PubMed Abstract | Publisher Full Text

[53] 53. Montenegro RA, Farinatti PDV, Fontes EB, et al.: Transcranial direct current stimulation influences the cardiac autonomic nervous control. Neurosci Lett. 2011; 497(1): 32–6. PubMed Abstract | Publisher Full Text

[54] 54. Schestatsky P, Simis M, Freeman R, et al.: Non-invasive brain stimulation and the autonomic nervous system. Clin Neurophysiol. 2013; 124: 1716–28. PubMed Abstract | Publisher Full Text

[55] 55. Luciana M, Collins PF, Depue RA: Opposing roles for dopamine and serotonin in the modulation of human spatial working memory functions. Cereb Cortex. 1998; 8(3): 218–26. PubMed Abstract | Publisher Full Text

[56] 56. Berridge KC: The debate over dopamine’s role in reward: the case for incentive salience. Psychopharmacology (Berl). 2007; 191(3): 391–431. PubMed Abstract | Publisher Full Text

[57] 57. Chamberlain SR, Müller U, Blackwell AD, et al.: Noradrenergic modulation of working memory and emotional memory in humans. Psychopharmacology (Berl). 2006; 188(4): 397–407. PubMed Abstract | Publisher Full Text

[58] 58. Koskinen T, Kä Hö Nen M, Jula A, et al.: The Cardiovascular Risk in Young Finns Study. Diabet Med. 2009; 26: 354–61.

[59] 59. Dietrich D, Rosmalen JGM, Althaus M, et al.: Reproducibility of heart rate variability and baroreflex sensitivity measurements in children. Biol Psychol. 2010; 85(1): 71–8. PubMed Abstract | Publisher Full Text

[60] 60. Guijt AM, Sluiter JK, Frings-Dresen MHW: Test-Retest Reliability of Heart Rate Variability and Respiration Rate at Rest and during Light Physical Activity in Normal Subjects. Arch Med Res. 2007; 38(1): 113–20. PubMed Abstract | Publisher Full Text

[61] 61. Mukherjee S, Yadav R, Yung I, et al.: Sensitivity to mental effort and test-retest reliability of heart rate variability measures in healthy seniors. Clin Neurophysiol. 2011; 122(10): 2059–66. PubMed Abstract | Publisher Full Text | Free Full Text

Effect of Transcranial Direct Current Stimulation associated with aerobic exercise on the autonomic modulation of hemiparetic individuals due to stroke: a study protocol for a double-blind randomized controlled trial

Abstract

Keywords

Revised Amendments from Version 1

Abbreviations

Introduction

Justification

The proposed study

Hypotheses

Methods

Study design

Figure 1. Flowchart of the study.

Sample recruitment and selection

Inclusion and Exclusion Criteria

Withdrawal and discontinuation

Sample size

Figure 2. Representation of the sample calculation by the site: calculoamostral.bauru.usp.br from Test t: by the difference between the two averages with independent groups, with α of 0.05 and a β of 0.80 between 2 groups in 4 periods and an effect size by Cohen's d.

Randomization

Study assessments schedule

Table 1. Standard protocol items: recommendations for interventional trials of this study.

Intervention

Blinding

Aerobic activity

Assessments

Determination of potential confounding factors

Discussion

Evaluation status

Dissemination of results

Study limitations

Data availability

Underlying data

Extended data

Reporting guidelines

Acknowledgments

References

Comments on this article Comments (0)

Open Peer Review

Comments on this article Comments (0)

Open Peer Review

Reviewer Status

Reviewer Reports

Comments on this article

Browse by related subjects

Competing Interests Policy

Stay Updated